QUARTERLY REPORT

Q1 FY2023 — Quarterly report (Form 10-Q)

Q1 FY2023PDF · 55 pages538 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2022
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission File Number: 000-06936
Commission Company Name: WD 40 CO
WD-40 COMPANY
(Exact name of registrant as specified in its charter)
Delaware 	95-1797918
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
9715 Businesspark Avenue, San Diego, California 	92131
(Address of principal executive offices) 	(Zip code)
Registrant’s telephone number, including area code: (619) 275-1400
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol 	Name of exchange on which registered
Common stock, par value $0.001 per share 	WDFC 	NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for
the past 90 days.
Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in
Rule 12b-2 of the Exchange Act.
Large accelerated filer þ 	Accelerated filer ¨ Non-accelerated filer ¨ 	Smaller reporting company ¨
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No þ
1

-- 1 of 55 --

The number of outstanding shares of the registrant’s common stock, par value $0.001 per share, as of January 3, 2023 was 13,587,596.
WD-40 COMPANY
QUARTERLY REPORT ON FORM 10-Q
For the Quarter Ended November 30, 2022
TABLE OF CONTENTS
PART I — FINANCIAL INFORMATION Page
Item 1. 	Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets 	3
Condensed Consolidated Statements of Operations 	4
Condensed Consolidated Statements of Comprehensive Income 	5
Condensed Consolidated Statements of Stockholders’ Equity 	6
Condensed Consolidated Statements of Cash Flows 	7
Notes to Condensed Consolidated Financial Statements 	8
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	18
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	33
Item 4. 	Controls and Procedures 	33
PART II — OTHER INFORMATION
Item 1. 	Legal Proceedings 	35
Item 1A. 	Risk Factors 	35
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	35
Item 6. 	Exhibits 	36
2

-- 2 of 55 --

PART 1 – FINANCIAL INFORMATION
Item 1. Financial Statements
WD-40 COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited and in thousands, except share and per share amounts)
November 30, 	August 31,
2022 	2022
Assets
Current assets:
Cash and cash equivalents 	$ 	36,882 	$ 	37,843
Trade and other accounts receivable, net 	87,285 	89,930
Inventories 	119,067 	104,101
Other current assets 	12,122 	17,766
Total current assets 	255,356 	249,640
Property and equipment, net 	65,658 	65,977
Goodwill 	95,277 	95,180
Other intangible assets, net 	5,362 	5,588
Operating lease right-of-use assets 	8,435 	7,559
Deferred tax assets, net 	629 	679
Other assets 	10,776 	9,672
Total assets 	$ 	441,493 	$ 	434,295
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable 	$ 	31,826 	$ 	32,852
Accrued liabilities 	24,728 	27,161
Accrued payroll and related expenses 	14,251 	11,583
Short-term borrowings 	42,537 	39,173
Income taxes payable 	301 	51
Total current liabilities 	113,643 	110,820
Long-term borrowings 	107,902 	107,139
Deferred tax liabilities, net 	10,715 	10,528
Long-term operating lease liabilities 	6,629 	5,999
Other long-term liabilities 	11,234 	11,185
Total liabilities 	250,123 	245,671
Commitments and Contingencies (Note 11)
Stockholders’ equity:
Common stock ― authorized 36,000,000 shares, $0.001 par value;
19,896,477 and 19,888,807 shares issued at November 30, 2022 and
August 31, 2022, respectively; and 13,587,596 and 13,602,346 shares
outstanding at November 30, 2022 and August 31, 2022, respectively 	20 	20
Additional paid-in capital 	168,092 	165,973
Retained earnings 	459,439 	456,076
Accumulated other comprehensive loss 	(34,873) 	(36,209)
Common stock held in treasury, at cost ― 6,308,881 and 6,286,461
shares at November 30, 2022 and August 31, 2022, respectively 	(401,308) 	(397,236)
Total stockholders’ equity 	191,370 	188,624
Total liabilities and stockholders’ equity 	$ 	441,493 	$ 	434,295
See accompanying notes to condensed consolidated financial statements.
3

-- 3 of 55 --

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited and in thousands, except per share amounts)
Three Months Ended November 30,
2022 	2021
Net sales 	$ 	124,893 	$ 	134,746
Cost of products sold 	60,638 	66,276
Gross profit 	64,255 	68,470
Operating expenses:
Selling, general and administrative 	39,984 	38,423
Advertising and sales promotion 	5,339 	5,624
Amortization of definite-lived intangible assets 	253 	363
Total operating expenses 	45,576 	44,410
Income from operations 	18,679 	24,060
Other income (expense):
Interest income 	44 	25
Interest expense 	(1,169) 	(620)
Other income (expense), net 	150 	(329)
Income before income taxes 	17,704 	23,136
Provision for income taxes 	3,707 	4,581
Net income 	$ 	13,997 	$ 	18,555
Earnings per common share:
Basic 	$ 	1.03 	$ 	1.35
Diluted 	$ 	1.02 	$ 	1.34
Shares used in per share calculations:
Basic 	13,590 	13,716
Diluted 	13,609 	13,752
See accompanying notes to condensed consolidated financial statements.
4

-- 4 of 55 --

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited and in thousands)
Three Months Ended November 30,
2022 	2021
Net income 	$ 	13,997 	$ 	18,555
Other comprehensive income (loss):
Foreign currency translation adjustment 	1,336 	(1,893)
Total comprehensive income 	$ 	15,333 	$ 	16,662
See accompanying notes to condensed consolidated financial statements.
5

-- 5 of 55 --

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited and in thousands, except share and per share amounts)
Accumulated
Additional 	Other 	Total
Common Stock 	Paid-in 	Retained 	Comprehensive 	Treasury Stock 	Stockholders’
Shares 	Amount 	Capital 	Earnings 	Income (Loss) 	Shares 	Amount 	Equity
Balance at August 31, 2022 	19,888,807 $ 	20 $ 165,973 $ 456,076 $ 	(36,209) 	6,286,461 $ (397,236) $ 188,624
Issuance of common stock under share-based
compensation plan, net of shares withheld for
taxes 	7,670 	- 	(600) 	(600)
Stock-based compensation 	2,719 	2,719
Cash dividends ($0.78 per share) 	(10,634) 	(10,634)
Acquisition of treasury stock 	22,420 	(4,072) 	(4,072)
Foreign currency translation adjustment 	1,336 	1,336
Net income 	13,997 	13,997
Balance at November 30, 2022 	19,896,477 $ 	20 $ 168,092 $ 459,439 $ 	(34,873) 	6,308,881 $ (401,308) $ 191,370
Accumulated
Additional 	Other 	Total
Common Stock 	Paid-in 	Retained 	Comprehensive 	Treasury Stock 	Stockholders’
Shares 	Amount 	Capital 	Earnings 	Income (Loss) 	Shares 	Amount 	Equity
Balance at August 31, 2021 	19,856,865 $ 	20 $ 163,737 $ 430,735 $ 	(26,030) 	6,147,899 $ (368,080) $ 200,382
Issuance of common stock under share-based
compensation plan, net of shares withheld for
taxes 	30,072 	- 	(4,246) 	(4,246)
Stock-based compensation 	2,891 	2,891
Cash dividends ($0.72 per share) 	(9,905) 	(9,905)
Acquisition of treasury stock 	32,000 	(7,386) 	(7,386)
Foreign currency translation adjustment 	(1,893) 	(1,893)
Net income 	18,555 	18,555
Balance at November 30, 2021 	19,886,937 $ 	20 $ 162,382 $ 439,385 $ 	(27,923) 	6,179,899 $ (375,466) $ 198,398
See accompanying notes to condensed consolidated financial statements.
6

-- 6 of 55 --

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited and in thousands)
Three Months Ended November 30,
2022 	2021
Operating activities:
Net income 	$ 	13,997 	$ 	18,555
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization 	1,896 	1,987
Net gains on sales and disposals of property and equipment 	122 	9
Deferred income taxes 	271 	738
Stock-based compensation 	2,719 	2,891
Unrealized foreign currency exchange losses (gains) 	(1,481) 	541
Provision for credit losses 	30 	30
Changes in assets and liabilities:
Trade and other accounts receivable 	2,847 	(7,980)
Inventories 	(14,203) 	(13,054)
Other assets 	4,573 	(1,793)
Operating lease assets and liabilities, net 	26 	2
Accounts payable and accrued liabilities 	(3,336) 	4,126
Accrued payroll and related expenses 	2,627 	(7,324)
Other long-term liabilities and income taxes payable 	349 	325
Net cash provided by (used in) operating activities 	10,437 	(947)
Investing activities:
Purchases of property and equipment 	(1,458) 	(2,434)
Proceeds from sales of property and equipment 	158 	72
Net cash used in investing activities 	(1,300) 	(2,362)
Financing activities:
Treasury stock purchases 	(4,072) 	(7,386)
Dividends paid 	(10,634) 	(9,905)
Repayments of long-term senior notes 	(400) 	(400)
Net proceeds from revolving credit facility 	3,364 	-
Shares withheld to cover taxes upon conversions of equity awards 	(600) 	(4,246)
Net cash used in financing activities 	(12,342) 	(21,937)
Effect of exchange rate changes on cash and cash equivalents 	2,244 	(1,196)
Net decrease in cash and cash equivalents 	(961) 	(26,442)
Cash and cash equivalents at beginning of period 	37,843 	85,961
Cash and cash equivalents at end of period 	$ 	36,882 	$ 	59,519
Supplemental disclosure of noncash investing activities:
Accrued capital expenditures 	$ 	315 	$ 	294
See accompanying notes to condensed consolidated financial statements.
7

-- 7 of 55 --

WD-40 COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
Note 1. The Company
WD-40 Company (the “Company”), incorporated in Delaware and based in San Diego, California, is a global marketing organization dedicated to creating
positive lasting memories by developing and selling products that solve problems in workshops, factories and homes around the world. The Company owns a
wide range of brands that include maintenance products and homecare and cleaning products: WD-40® Multi-Use Product, WD-40 Specialist®, 3-IN-ONE®,
GT85®, X-14®, 2000 Flushes®, Carpet Fresh®, no vac®, Spot Shot®, 1001®, Lava® and Solvol®.
The Company’s products are sold in various locations around the world. Maintenance products are sold worldwide in markets throughout North, Central and
South America, Asia, Australia, Europe, the Middle East and Africa. Homecare and cleaning products are sold primarily in North America, the United Kingdom
(“U.K.”) and Australia. The Company’s products are sold primarily through warehouse club stores, hardware stores, automotive parts outlets, industrial
distributors and suppliers, mass retail and home center stores, value retailers, grocery stores, online retailers, farm supply, sport retailers, and independent bike
dealers.
Note 2. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Consolidation
The condensed consolidated financial statements included herein have been prepared by the Company, without audit, according to the rules and regulations of
the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such
rules and regulations. The August 31, 2022 year-end condensed consolidated balance sheet data was derived from audited financial statements but does not
include all disclosures required by U.S. GAAP.
In the opinion of management, the unaudited financial information for the interim periods shown reflects all adjustments necessary for a fair statement
thereof and such adjustments are of a normal recurring nature. These condensed consolidated financial statements should be read in conjunction with the
consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2022, which
was filed with the SEC on October 24, 2022.
The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and
balances have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting periods. Actual results could materially differ from those estimates. Operating results for interim periods
are not necessarily indicative of operating results for an entire fiscal year.
The COVID-19 pandemic has adversely impacted global economic conditions and has contributed to significant volatility in financial markets beginning in
early calendar year 2020. Although the Company’s estimates consider current conditions, the inputs into certain of the Company’s significant and critical
accounting estimates include judgments and assumptions about the economic implications of the COVID-19 pandemic and how management expects them to
change in the future, as appropriate. It is reasonably possible that actual results experienced may differ materially from the Company’s estimates in future
periods, which could materially affect our results of operations and financial condition.
8

-- 8 of 55 --

Foreign Currency Forward Contracts
In the normal course of business, the Company employs established policies and procedures to manage its exposure to fluctuations in foreign currency
exchange rates. The Company utilizes foreign currency forward contracts to limit its exposure to net asset balances held in non-functional currencies, primarily
at its U.K. subsidiary. The Company regularly monitors its foreign currency exchange rate exposures to ensure the overall effectiveness of its foreign currency
hedge positions. While the Company engages in foreign currency hedging activity to reduce its risk, for accounting purposes, none of its foreign currency
forward contracts are designated as hedges.
Foreign currency forward contracts are carried at fair value, with net realized and unrealized gains and losses recognized in other income (expense), net in the
Company’s consolidated statements of operations. Cash flows from settlements of foreign currency forward contracts are included in operating activities in the
consolidated statements of cash flows. Foreign currency forward contracts in an asset position at the end of the reporting period are included in other current
assets, while foreign currency forward contracts in a liability position at the end of the reporting period are included in accrued liabilities in the Company’s
consolidated balance sheets. At November 30, 2022, the Company had no outstanding foreign currency forward contracts. Unrealized net gains and losses
related to foreign currency forward contracts were not significant at November 30, 2022 and August 31, 2022. Realized net gains and losses related to foreign
currency forward contracts were not significant for the three months ended November 30, 2022 and 2021. Both unrealized and realized net gains and losses are
recorded in other income (expense), net on the Company’s condensed consolidated statements of operations.
Fair Value of Financial Instruments
Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures”, defines fair value as the exchange price that would be received
for an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial
assets and liabilities measured at fair value into a hierarchy that categorizes fair value measurements into the following three levels based on the types of inputs
used in measuring their fair value:
Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities;
Level 2: Observable market-based inputs or observable inputs that are corroborated by market data; and
Level 3: Unobservable inputs reflecting the Company’s own assumptions.
Under fair value accounting, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value
measurement. The Company has no assets or liabilities that are measured at fair value in the financial statements on a recurring basis, except for foreign
currency forward contracts, into which the Company enters from time to time, and are classified as Level 2 within the fair value hierarchy. The carrying values
of cash equivalents and short-term borrowings are recorded at cost, which approximates their fair values, primarily due to their short-term nature. In addition,
the carrying value of borrowings held under the Company’s revolving credit facility approximates fair value, based on Level 2 inputs, due to the variable nature
of underlying interest rates, which generally reflect market conditions. The Company’s fixed rate long-term borrowings consist of senior notes and are recorded
at carrying value. The Company estimates that the fair value of its senior notes, based on Level 2 inputs, was approximately $60.8 million as of November 30,
2022, which was determined based on a discounted cash flow analysis using current market interest rates for instruments with similar terms, compared to their
carrying value of $68.0 million. During the three months ended November 30, 2022, the Company did not record any significant nonrecurring fair value
measurements for assets or liabilities in periods subsequent to their initial recognition.
9

-- 9 of 55 --

Note 3. Inventories
Inventories are stated at the lower of cost or net realizable value and cost is determined based on a first-in, first-out method or, for a portion of raw materials
inventory, the average cost method.
Inventories consisted of the following (in thousands):
November 30, 	August 31,
2022 	2022
Product held at third-party contract manufacturers 	$ 	6,000 	$ 	7,915
Raw materials and components 	17,723 	13,952
Work-in-process 	408 	881
Finished goods 	94,936 	81,353
Total 	$ 	119,067 	$ 	104,101
Note 4. Property and Equipment and Capitalized Cloud-Based Software Implementation Costs
Property and equipment, net, consisted of the following (in thousands):
November 30, 	August 31,
2022 	2022
Machinery, equipment and vehicles 	$ 	44,489 	$ 	44,533
Buildings and improvements 	26,521 	27,958
Computer and office equipment 	6,106 	5,757
Internal-use software 	9,884 	9,591
Furniture and fixtures 	2,693 	2,669
Capital in progress 	10,333 	10,135
Land 	4,164 	4,240
Subtotal 	104,190 	104,883
Less: accumulated depreciation and amortization 	(38,532) 	(38,906)
Total 	$ 	65,658 	$ 	65,977
As of November 30, 2022 and August 31, 2022, the Company’s condensed consolidated balance sheets included $7.6 million and $6.5 million, respectively, of
capitalized cloud-based implementation costs recorded as other assets within the Company’s condensed consolidated balance sheets. These balances primarily
consist of capitalized costs related to the new cloud-based enterprise resource planning system which we are in the process of implementing. Accumulated
amortization associated with cloud-based implementation costs were $0.5 million as of both November 30, 2022 and August 31, 2022. Amortization expense
associated with these assets were not significant during the three months ended November 30, 2022 or 2021.
10

-- 10 of 55 --

Note 5. Goodwill and Other Intangible Assets
Goodwill
The following table summarizes the changes in the carrying amounts of goodwill by segment (in thousands):
Americas 	EMEA 	Asia-Pacific 	Total
Balance as of August 31, 2022 	$ 	85,402 	$ 	8,569 	$ 	1,209 	$ 	95,180
Translation adjustments 	10 	87 	- 	97
Balance as of November 30, 2022 	$ 	85,412 	$ 	8,656 	$ 	1,209 	$ 	95,277
There were no indicators of impairment identified as a result of the Company’s review of events and circumstances related to its goodwill subsequent to
December 1, 2021, the date of its most recent annual goodwill impairment test, which was a qualitative assessment conducted during the second quarter of
fiscal year 2022. Based on the results of the annual goodwill impairment test, the estimated fair value of each of the Company’s reporting units exceeded their
respective carrying values so significantly that an impairment charge to the Company’s goodwill balances is remote and, thus, a quantitative analysis was not
required. To date, there have been no impairment losses identified and recorded related to the Company’s goodwill.
Definite-lived Intangible Assets
The Company’s definite-lived intangible assets, which include the Spot Shot, Carpet Fresh, 1001, EZ REACH and GT85 trade names, are included in other
intangible assets, net in the Company’s condensed consolidated balance sheets.
The following table summarizes the definite-lived intangible assets and the related accumulated amortization (in thousands):
November 30, 	August 31,
2022 	2022
Gross carrying amount 	$ 	35,382 	$ 	35,166
Accumulated amortization 	(30,020) 	(29,578)
Net carrying amount 	$ 	5,362 	$ 	5,588
There has been no impairment charge for the three months ended November 30, 2022 and there were no indicators of impairment identified as a result of the
Company’s review of events and circumstances related to its existing definite-lived intangible assets.
Changes in the carrying amounts of definite-lived intangible assets by segment for the three months ended November 30, 2022 are summarized below (in
thousands):
Americas 	EMEA 	Asia-Pacific 	Total
Balance as of August 31, 2022 	$ 	4,437 	$ 	1,151 	$ 	- 	$ 	5,588
Amortization expense 	(207) 	(46) 	- 	(253)
Translation adjustments 	- 	27 	- 	27
Balance as of November 30, 2022 	$ 	4,230 	$ 	1,132 	$ 	- 	$ 	5,362
The estimated amortization expense for the Company’s definite-lived intangible assets is not significant in any future individual fiscal year.
11

-- 11 of 55 --

Note 6. Accrued and Other Liabilities
Accrued liabilities consisted of the following (in thousands):
November 30, 	August 31,
2022 	2022
Accrued advertising and sales promotion expenses 	$ 	13,286 	$ 	13,563
Accrued professional services fees 	1,648 	1,979
Accrued sales taxes and other taxes 	1,456 	995
Deferred revenue 	2,403 	4,988
Short-term operating lease liability 	1,951 	1,703
Other 	3,984 	3,933
Total 	$ 	24,728 	$ 	27,161
Accrued payroll and related expenses consisted of the following (in thousands):
November 30, 	August 31,
2022 	2022
Accrued incentive compensation 	$ 	2,546 	$ 	2,524
Accrued payroll 	4,777 	4,001
Accrued profit sharing 	4,055 	2,758
Accrued payroll taxes 	2,351 	1,779
Other 	522 	521
Total 	$ 	14,251 	$ 	11,583
Note 7. Debt
As of November 30, 2022, the Company held borrowings under two separate agreements as detailed below.
Note Purchase and Private Shelf Agreement
The Company holds borrowings under its Note Purchase and Private Shelf Agreement, as amended (the “Note Agreement”) by and among the Company,
PGIM, Inc. (“Prudential”), and certain affiliates and managed accounts of Prudential (the “Note Purchasers”). As of November 30, 2022, the Company had
outstanding balances on its series A, B and C notes issued under this Note Agreement.
Credit Agreement
The Company’s Amended and Restated Credit Agreement, as amended (the “Credit Agreement”) with Bank of America, N.A. consists of a revolving
commitment for borrowing by the Company up to $150.0 million with a sublimit of $100.0 million for WD-40 Company Limited, a wholly owned operating
subsidiary of the Company for Europe, the Middle East, Africa and India.
On November 29, 2021, the Company entered into its most recent amendment to the Credit Agreement (the “LIBOR Amendment”) with Bank of America, N.A.
The LIBOR Amendment changed the Company’s index rates under the Credit Agreement for Pound Sterling and U.S. Dollar borrowings from the London
Interbank Offered Rate as administered by ICE Benchmark Administration to the Sterling Overnight Index Average Reference Rate and the Bloomberg Short-
term Bank Yield Index rate, respectively, as well as certain definitions and clarifications within the Credit Agreement to accommodate the change in index rates.
The impact of the LIBOR Amendment was insignificant to the Company’s consolidated financial statements.
12

-- 12 of 55 --

Short-term and long-term borrowings under the Company’s Credit Agreement and Note Agreement consisted of the following (in thousands):
November 30, 	August 31,
Issuance 	Maturities 	2022 	2022
Credit Agreement – revolving credit facility (1) 	Various 	9/30/2025 	$ 	82,439 	$ 	77,912
Note Agreement
Series A Notes – 3.39% fixed rate(2) 	11/15/2017 	2021-2032 	16,000 	16,400
Series B Notes – 2.50% fixed rate(3) 	9/30/2020 	11/15/2027 	26,000 	26,000
Series C Notes – 2.69% fixed rate(3) 	9/30/2020 	11/15/2030 	26,000 	26,000
Total borrowings 	150,439 	146,312
Short-term portion of borrowings 	(42,537) 	(39,173)
Total long-term borrowings 	$ 	107,902 	$ 	107,139
(1) The Company can refinance any draw under the line of credit with successive short-term borrowings through the maturity date. Outstanding draws for which management has the ability
and intent to refinance with successive short-term borrowings for a period of at least twelve months are classified as long-term. As of November 30, 2022, $40.7 million on this facility is
classified as long-term and is denominated in Euros and Pound Sterling, whereas $41.7 million is classified as short-term and is denominated entirely in U.S. Dollar. Euro and Pound
Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency exchange rates.
(2) Principal payments are required semi-annually in May and November of each year in equal installments of $0.4 million through May 15, 2032, resulting in $0.8 million classified as short-
term. The remaining outstanding principal in the amount of $8.4 million will become due on November 15, 2032.
(3) Interest on notes is payable semi-annually in May and November of each year with no principal due until the maturity date.
Both the Note Agreement and the Credit Agreement contain representations, warranties, events of default and remedies, as well as affirmative, negative and
other financial covenants customary for these types of agreements. These covenants include, among other things, certain limitations on the ability of the
Company and its subsidiaries to incur indebtedness, create liens, dispose of assets, make investments, declare, make or incur obligations to make certain
restricted payments, including payments for the repurchase of the Company’s capital stock and enter into certain merger or consolidation transactions. The
Credit Agreement includes, among other limitations on indebtedness, a $125.0 million limit on other unsecured indebtedness.
Each agreement also includes a most favored lender provision which requires that any time any other lender has the benefit of one or more financial or
operational covenants that is different than, or similar to, but more restrictive than those contained in its own agreement, those covenants shall be immediately
and automatically incorporated by reference to the other lender’s agreement. Both the Note Agreement and the Credit Agreement require the Company to
adhere to the same financial covenants. For the financial covenants, the definition of consolidated EBITDA includes the add back of non-cash stock-based
compensation to consolidated net income when arriving at consolidated EBITDA. The terms of the financial covenants are as follows:
· The consolidated leverage ratio cannot be greater than three and a half to one. The consolidated leverage ratio means, as of any date of determination,
the ratio of (a) consolidated funded indebtedness as of such date to (b) consolidated EBITDA for the most recently completed four fiscal quarters.
· The consolidated interest coverage ratio cannot be less than three to one. The consolidated interest coverage ratio means, as of any date of
determination, the ratio of (a) consolidated EBITDA for the most recently completed four fiscal quarters to (b) consolidated interest charges for the
most recently completed four fiscal quarters
As of November 30, 2022, the Company was in compliance with all debt covenants under both the Note Agreement and the Credit Agreement.
13

-- 13 of 55 --

Note 8. Share Repurchase Plan
On October 12, 2021, the Company’s Board of Directors (“Board”) approved a new share repurchase plan. Under the plan, which became effective on
November 1, 2021, the Company is authorized to acquire up to $75.0 million of its outstanding shares through August 31, 2023. The timing and amount of
repurchases are based on terms and conditions as may be acceptable to the Company’s Chief Executive Officer and Chief Financial Officer, subject to present
loan covenants and in compliance with all laws and regulations applicable thereto. During the period from November 1, 2021 through November 30, 2022, the
Company repurchased 160,982 shares at an average price of $206.38 per share, for a total cost of $33.2 million under this $75.0 million plan. During the three
months ended November 30, 2022, the Company repurchased 22,420 shares at an average price of $181.60 per share, for a total cost of $4.1 million under this
$75.0 million plan.
Note 9. Earnings per Common Share
The table below reconciles net income to net income available to common stockholders (in thousands):
Three Months Ended November 30,
2022 	2021
Net income 	$ 	13,997 	$ 	18,555
Less: Net income allocated to
participating securities 	(54) 	(64)
Net income available to common stockholders 	$ 	13,943 	$ 	18,491
The table below summarizes the weighted-average number of common shares outstanding included in the calculation of basic and diluted EPS (in thousands):
Three Months Ended November 30,
2022 	2021
Weighted-average common
shares outstanding, basic 	13,590 	13,716
Weighted-average dilutive securities 	19 	36
Weighted-average common
shares outstanding, diluted 	13,609 	13,752
For the three months ended November 30, 2022 and 2021, weighted-average stock-based equity awards outstanding that are non-participating securities in the
amount of 7,471 and 5,145, respectively, were excluded from the calculation of diluted EPS under the treasury stock method as they were anti-dilutive.
14

-- 14 of 55 --

Note 10. Revenue Recognition
Disaggregation of Revenue
The following table presents our revenues by segment and major source (in thousands):	:
Three Months Ended November 30, 2022:
Americas 	EMEA 	Asia-Pacific 	Total
Maintenance products 	$ 	53,571 	$ 	38,729 	$ 	24,012 	$ 	116,312
HCCP (1) 	4,443 	2,043 	2,095 	8,581
Total net sales 	$ 	58,014 	$ 	40,772 	$ 	26,107 	$ 	124,893
Three Months Ended November 30, 2021:
Americas 	EMEA 	Asia-Pacific 	Total
Maintenance products 	$ 	51,984 	$ 	55,443 	$ 	18,603 	$ 	126,030
HCCP (1) 	4,304 	2,112 	2,300 	8,716
Total net sales 	$ 	56,288 	$ 	57,555 	$ 	20,903 	$ 	134,746
(1) Homecare and cleaning products (“HCCP”)
Contract Balances
Contract liabilities consist of deferred revenue related to undelivered products. Deferred revenue is recorded when payments have been received from
customers for undelivered products. Revenue is subsequently recognized when revenue recognition criteria are met, generally when control of the product
transfers to the customer. The Company had contract liabilities of $2.4 million and $5.0 million as of November 30, 2022 and August 31, 2022, respectively. All
of the $5.0 million that was included in contract liabilities as of August 31, 2022 was recognized to revenue during the three months ended November 30, 2022.
These contract liabilities are recorded in accrued liabilities on the Company’s condensed consolidated balance sheets. Contract assets are recorded if the
Company has satisfied a performance obligation but does not yet have an unconditional right to consideration. The Company did not have any contract assets as
of November 30, 2022 and August 31, 2022. The Company has an unconditional right to payment for its trade and other accounts receivable on the Company’s
condensed consolidated balance sheets. These receivables are presented net of an allowance for doubtful accounts, which were insignificant at both November
30, 2022 and August 31, 2022.
Note 11. Commitments and Contingencies
Purchase Commitments
The Company has ongoing relationships with various suppliers (contract manufacturers) that manufacture the Company’s products and third-party distribution
centers that warehouse and ship the Company’s products to customers. The contract manufacturers maintain title and control of certain raw materials and
components, materials utilized in finished products, and the finished products themselves until shipment to the Company’s third-party distribution centers or
customers in accordance with agreed upon shipment terms. Although the Company has definitive minimum purchase obligations included in the contract terms
with certain of its contract manufacturers, when such obligations have been included, they have either been immaterial or the minimum amounts have been such
that they are well below the volume of goods that the Company has historically purchased. In the ordinary course of business, supply needs are communicated
by the Company to its contract manufacturers based on orders and short-term projections, ranging from two months to six months. The Company is committed
to purchase the products produced by the contract manufacturers based on the projections provided.
Upon the termination of contracts with contract manufacturers, the Company obtains certain inventory control rights and is obligated to work with the contract
manufacturer to sell through all product held by or manufactured by the contract manufacturer on behalf of the Company during the termination notification
period. If any inventory remains at the contract manufacturer at the termination date, the Company is obligated to purchase such inventory, which may include
raw materials,
15

-- 15 of 55 --

components and finished goods. The amounts for inventory purchased under termination commitments have been immaterial.
In addition to the commitments to purchase products from contract manufacturers described above, the Company may also enter into commitments with other
manufacturers to purchase finished goods and components to support innovation and renovation initiatives and/or supply chain initiatives. As of November 30,
2022, no such commitments were outstanding.
Litigation
From time to time, the Company is subject to various claims, lawsuits, investigations and proceedings arising in the ordinary course of business, including but
not limited to, product liability litigation and other claims and proceedings with respect to intellectual property, breach of contract, labor and employment, tax
and other matters. As of November 30, 2022, there were no unasserted claims or pending proceedings for claims against the Company that the Company
believes will result in a probable loss. As to claims that the Company believes may result in a reasonably possible loss, the Company believes that no reasonably
possible outcome of any such claim will have a materially adverse impact on the Company’s financial condition, results of operations or cash flows.
Indemnifications
As permitted under Delaware law, the Company has agreements whereby it indemnifies senior officers and directors for certain events or occurrences while the
officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential amount of future payments the Company could be
required to make under these indemnification agreements is unlimited; however, the Company maintains Director and Officer insurance coverage that mitigates
the Company’s exposure with respect to such obligations. As a result of the Company’s insurance coverage, management believes that the estimated fair value
of these indemnification agreements is minimal. Thus, no liabilities have been recorded for these agreements as of November 30, 2022.
From time to time, the Company enters into indemnification agreements with certain contractual parties in the ordinary course of business, including
agreements with lenders, lessors, contract manufacturers, marketing distributors, customers and certain vendors. All such indemnification agreements are
entered into in the context of the particular agreements and are provided in an attempt to properly allocate risk of loss in connection with the consummation of
the underlying contractual arrangements. Although the maximum amount of future payments that the Company could be required to make under these
indemnification agreements is unlimited, management believes that the Company maintains adequate levels of insurance coverage to protect the Company with
respect to most potential claims arising from such agreements and that such agreements do not otherwise have value separate and apart from the liabilities
incurred in the ordinary course of the Company’s business. Thus, no liabilities have been recorded with respect to such indemnification agreements as of
November 30, 2022.
Note 12. Income Taxes
The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities
available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items
are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter.
The provision for income taxes was 20.9% and 19.8% of income before income taxes for the three months ended November 30, 2022 and 2021, respectively.
The increase in the effective income tax rate from period to period was primarily due to tax shortfalls from the settlements of stock-based equity awards,
partially offset by a one-time tax-deductible charitable donation. The Company recorded tax shortfalls related to settlements of stock-based equity awards of
$0.7 million during the first quarter of fiscal year 2023 compared to insignificant tax benefits related to these types of settlements in the first quarter of fiscal
year 2022, resulting in a 5.1% unfavorable impact on the Company’s effective tax rate from period to period. Partially offsetting this unfavorable impact was a
one-time tax benefit associated with the Company’s donation of its former corporate headquarters building to a local San Diego community foundation that
occurred in the first quarter of fiscal year 2023, resulting in a 4.2% favorable impact on the Company’s effective tax rate. The building, net of its tax basis, is
estimated to result in a charitable donation of $3.5 million and an approximate tax benefit of $0.7 million.
16

-- 16 of 55 --

The Company is subject to taxation in the U.S. and in various state and foreign jurisdictions. Due to expired statutes, the Company’s federal income tax returns
for years prior to fiscal year 2018 are not subject to examination by the U.S. Internal Revenue Service. Generally, for the majority of state and foreign
jurisdictions where the Company does business, periods prior to fiscal year 2018 are no longer subject to examination. The Company is currently under audit in
various state jurisdictions for fiscal years 2018 through 2019. Estimated unrecognized tax benefits related to income tax positions affected by the resolution of
tax examinations or expiring statutes of limitation within the next twelve months were not significant. Audit outcomes and the timing of settlements are subject
to significant uncertainty.
Note 13. Business Segments and Foreign Operations
The Company evaluates the performance of its segments and allocates resources to them based on sales and income from operations. The Company is organized
on the basis of geographical area into the following three segments: the Americas; EMEA; and Asia-Pacific. Unallocated corporate expenses are general
corporate overhead expenses not directly attributable to the business segments and are reported separate from the Company’s identified segments. The corporate
overhead costs include expenses for the Company’s accounting and finance, information technology, human resources, research and development, quality
control and executive management functions, as well as all direct costs associated with public company compliance matters including legal, audit and other
professional services costs.
Summary information about reportable segments is as follows (in thousands):
Unallocated
For the Three Months Ended 	Americas 	EMEA 	Asia-Pacific 	Corporate (1) 	Total
November 30, 2022:
Net sales 	$ 	58,014 	$ 	40,772 	$ 	26,107 	$ 	- 	$ 	124,893
Income from operations 	$ 	12,772 	$ 	6,283 	$ 	9,617 	$ 	(9,993) 	$ 	18,679
Depreciation and
amortization expense 	$ 	878 	$ 	897 	$ 	45 	$ 	76 	$ 	1,896
Interest income 	$ 	4 	$ 	9 	$ 	31 	$ 	- 	$ 	44
Interest expense 	$ 	890 	$ 	279 	$ 	- 	$ 	- 	$ 	1,169
November 30, 2021:
Net sales 	$ 	56,288 	$ 	57,555 	$ 	20,903 	$ 	- 	$ 	134,746
Income from operations 	$ 	12,017 	$ 	14,213 	$ 	7,302 	$ 	(9,472) 	$ 	24,060
Depreciation and
amortization expense 	$ 	1,043 	$ 	784 	$ 	74 	$ 	86 	$ 	1,987
Interest income 	$ 	- 	$ 	- 	$ 	25 	$ 	- 	$ 	25
Interest expense 	$ 	498 	$ 	121 	$ 	1 	$ 	- 	$ 	620
(1) Unallocated corporate expenses are general corporate overhead expenses not directly attributable to any one of the business segments. These expenses are reported separately from the
Company’s identified segments and are included in Selling, General and Administrative expenses on the Company’s condensed consolidated statements of operations.
The Company’s Chief Operating Decision Maker does not review assets by segment as part of the financial information provided, and therefore, no asset
information is provided in the above table.
Note 14. Subsequent Event
Dividend Declaration
On December 13, 2022, the Company’s Board approved a 6% increase in the regular quarterly cash dividend, increasing it from $0.78 per share to $0.83 per
share. The $0.83 per share dividend declared on December 13, 2022 is payable on January 31, 2023 to stockholders of record on January 13, 2023.
17

-- 17 of 55 --

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
As used in this report, the terms “we,” “our,” and “us” refer to WD-40 Company and its wholly-owned subsidiaries, unless the context suggests otherwise.
Amounts and percentages in tables and discussions may not total due to rounding.
The following information is provided as a supplement to, and should be read in conjunction with, the unaudited condensed consolidated financial statements
and notes thereto included in Part I―Item 1 of this Quarterly Report and the audited consolidated financial statements and notes thereto and Management’s
Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended August 31,
2022, which was filed with the Securities and Exchange Commission (“SEC”) on October 24, 2022.
Use of Non-GAAP Constant Currency
In order to show the impact of changes in foreign currency exchange rates on our results of operations, we have included constant currency disclosures, where
necessary, in the Overview and Results of Operations sections which follow. Constant currency disclosures represent the translation of our current fiscal year
revenues, expenses and net income from the functional currencies of our subsidiaries to U.S. Dollars using the exchange rates in effect for the corresponding
period of the prior fiscal year. Results on a constant currency basis are not in accordance with accounting principles generally accepted in the United States of
America (“non-GAAP”) and should be considered in addition to, not as a substitute for, results prepared in accordance with U.S. GAAP. We use results on a
constant currency basis as one of the measures to understand our operating results and evaluate our performance in comparison to prior periods in order to
enhance the visibility of the underlying business trends, excluding the impact of translation arising from foreign currency exchange rate fluctuations.
Management believes this non-GAAP financial measure provides investors with additional financial information that should be considered when assessing our
underlying business performance and trends. However, reference to constant currency basis should not be considered in isolation or as a substitute for other
financial measures calculated and presented in accordance with U.S. GAAP.
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for certain forward-looking statements. This report contains forward-looking
statements, which reflect our current views with respect to future events and financial performance. These forward-looking statements are generally identified
with words such as “believe,” “expect,” “intend,” “plan,” “could,” “may,” “aim,” “anticipate,” “target,” “estimate” and similar expressions.
These forward-looking statements include, but are not limited to, discussions about future financial and operating results, including: growth expectations for
maintenance products; expected levels of promotional and advertising spending; anticipated input costs for manufacturing and the costs associated with
distribution of our products; plans for and success of product innovation, the impact of new product introductions on the growth of sales; anticipated results
from product line extension sales; expected tax rates and the impact of tax legislation and regulatory action; the length and severity of the current COVID-19
pandemic and its impact on the global economy and our financial results; changes in the political conditions or relations between the United States and other
nations, the impacts from inflationary trends and supply chain constraints; and forecasted foreign currency exchange rates and commodity prices. We undertake
no obligation to revise or update any forward-looking statements.
Actual events or results may differ materially from those projected in forward-looking statements due to various factors, including, but not limited to, those
identified in Part I―Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022, and in Part II—Item 1A, “Risk
Factors” of this Quarterly Report on Form 10-Q.
Overview
The Company
WD-40 Company (the “Company”), based in San Diego, California, is a global marketing organization dedicated to creating positive lasting memories by
developing and selling products that solve problems in workshops, factories and homes around the world. We own a wide range of well-known brands that
include maintenance products and homecare and cleaning
18

-- 18 of 55 --

products: WD-40® Multi-Use Product, WD-40 Specialist®, 3-IN-ONE®, GT85®, X-14®, 2000 Flushes®, Carpet Fresh®, no vac®, Spot Shot®, 1001®,
Lava® and Solvol®.
Our products are sold in various locations around the world. Maintenance products are sold worldwide in markets throughout North, Central and South
America, Asia, Australia, Europe, the Middle East and Africa. Homecare and cleaning products are sold primarily in North America, the United Kingdom
(“U.K.”) and Australia. We sell our products primarily through warehouse club stores, hardware stores, automotive parts outlets, industrial distributors and
suppliers, mass retail and home center stores, value retailers, grocery stores, online retailers, farm supply, sport retailers, and independent bike dealers.
Highlights
The following summarizes the financial and operational highlights for our business during the three months ended November 30, 2022:
· Consolidated net sales decreased $9.8 million, or 7%, compared to the corresponding period of the prior fiscal year. Increases in the average selling
price of our products positively impacted net sales by approximately $26.3 million from period to period, primarily due to sales price increases
implemented across all segments over the last twelve months. These favorable impacts were more than offset by decreases in sales volume, which
unfavorably impacted net sales by approximately $26.6 million from period to period. Changes to net sales attributable to volumes and average
selling price of our products are impacted by differences in sales mix related to products, markets and distribution channels from period to period.
In addition, changes in foreign currency exchange rates from period to period had an unfavorable impact of $9.5 million on consolidated net sales
for the first quarter of fiscal year 2023. On a constant currency basis, net sales would have decreased less than 1% from period to period. This
unfavorable impact from changes in foreign currency exchange rates mainly came from our EMEA segment, which accounted for 33% of our
consolidated sales for the three months ended November 30, 2022.
· Gross profit as a percentage of net sales increased to 51.4% compared to 50.8% for the corresponding period of the prior fiscal year primarily due
to the positive impacts of price increases implemented over the last twelve months, offset by ongoing global supply chain challenges, including the
increased cost of raw materials and constraints that began during the COVID-19 pandemic. These ongoing challenges have resulted in increased
inflation rates globally. See the Impact of COVID-19 on Our Business section which follows for details, including actions the Company continues to
take in response to these challenges.
· Consolidated net income decreased $4.6 million, or 25%, compared to the corresponding period of the prior fiscal year. Changes in foreign currency
exchange rates from period to period had an unfavorable impact of $1.2 million on consolidated net income for the first quarter of fiscal year 2023.
Thus, on a constant currency basis, net income would have decreased $3.3 million, or 18%, from period to period.
· Diluted earnings per common share were $1.02 versus $1.34 in the prior fiscal year period.
Our strategic initiatives and the areas where we will continue to focus our time, talent and resources in future periods include: (i) building a business for the
future; (ii) attracting, developing and engaging outstanding tribe members; (iii) striving for operational excellence; (iv) growing WD-40 Multi-Use Product; (v)
growing WD-40 Specialist product line; and (vi) expanding and supporting portfolio opportunities that help us grow.
Significant Developments
Impact of COVID-19 on Our Business
Our financial results and operations continue to be impacted by the COVID-19 pandemic that began during our fiscal year 2020. The ongoing COVID-19
pandemic has impacted global economies, the rate of inflation, supply chains, distribution networks and consumer behavior around the world. We have
experienced both favorable and unfavorable impacts to our financial results and our operations as a result of the direct and indirect effects of the COVID-19
pandemic. For example, sales have been negatively impacted at varying times in the regions in which we operate due to health and safety restrictions
19

-- 19 of 55 --

required by local governmental authorities. Such restrictions continue to sporadically impact various regions, particularly in certain countries within our Asia-
Pacific segment. Fluctuations in global economic conditions may impact end-user demand for our products in certain regions at varying times and are difficult
to predict. These changes in demand may significantly impact our financial results from period to period.
In addition, global supply chain issues have resulted in increased raw material costs and other input costs, higher competition for freight resources, and labor
constraints within manufacturing and distribution networks. This inflationary environment started to negatively impact our gross margin and financial results in
fiscal year 2021 and these trends have continued to increase our cost of goods sold since that time. Some of the supply chain challenges that we have
experienced in recent fiscal years include general aerosol production capacity constraints and competition for such capacity by other companies who also utilize
third-party manufacturers for their aerosol production. These challenges have periodically resulted in us not being able to meet demand for our products by
customers and end-users in certain markets at various times. We have continued to actively manage periodic supply chain constraints and transportation
disruptions and implement various initiatives with our existing third-party manufacturers as well as identifying and onboarding new third-party manufacturers,
particularly in the Americas and EMEA segments. In addition, we have taken actions to increase inventory levels of certain raw materials, components and
finished goods, given the current challenges within supply chain and increased lead times required by suppliers. As a result of these initiatives, we experienced
increases in the capacity and flexibility of our supply chain throughout fiscal year 2022 and this has improved further as we have started our fiscal year 2023,
particularly in the Americas segment. Although we are not able to estimate the costs or impacts associated with potential future supply chain disruptions, we
believe that the changes we continue to implement as a result of the pandemic will have a positive lasting impact on our ability to better manage any future
disruptions. However, some of the additional costs resulting from these recent supply chain constraints, including costs resulting from maintenance of higher
inventory levels, as well as the inflationary environment that is impacting our raw material costs, are expected to unfavorably impact our cost of goods sold for
as long as such conditions exist.
To offset the unfavorable impact of increased costs to our gross margin, price increases have been implemented across all of our markets and geographies in
fiscal year 2022 and in the first fiscal quarter of 2023 and we intend to implement further price increases in certain regions for the remainder of fiscal year 2023.
Although we are seeing the favorable impacts of these price increases, sales volumes are often impacted unfavorably in the short term as customers and end
users adjust to increased sales prices. The severity and duration of the COVID-19 pandemic and its effects on our supply chain, changes in end-user demand
and the current inflationary environment remain uncertain and it is not possible to estimate the extent to which these conditions will impact our financial results
and operations in future periods.
See our risk factors disclosed in Part I―Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2022, which was
filed with the SEC on October 24, 2022 for further information on risks associated with pandemics, including COVID-19.
The Impact of Russian Military Action in Ukraine
On February 24, 2022, Russian forces launched significant military action against Ukraine, which has resulted in conflict and disruption in the region. In
response to this action taken by Russia, the U.S. and other countries immediately imposed various economic sanctions against Russia. These geopolitical
tensions continued throughout the first quarter of fiscal year 2023 and this event has continued to impact global economies, particularly in Europe. It is
uncertain when conditions will improve or whether additional governmental sanctions will be enacted in future periods. The direct and indirect impacts of this
evolving situation and its effect on global economies in future periods are difficult to predict. We suspended selling our products to markets in Russia and
Belarus beginning in March 2022, which had an unfavorable impact on our sales. In addition, we were temporarily unable to sell our products in Ukraine due to
the disruption in the country, but sales to Ukraine resumed in the first quarter of fiscal year 2023. Prior to the suspension of sales in Russia and Belarus, our net
sales to these two regions were approximately 3% to 4% of consolidated net sales, the majority of which is related to Russia. We do not have facilities, third-
party manufacturing partners, employees or inventory in these affected regions. Additionally, the only activities we conducted in these regions prior to the
suspension of sales were through local marketing distributors. Write-offs of previously existing accounts receivable from those marketing distributors affected
by the crisis have not been significant to date and are not expected to become significant in future periods.
As a result of this conflict, commodity markets remain subject to heightened levels of uncertainty, especially as they relate to the price of crude oil, which
increased significantly in the immediate aftermath of the sanctions against Russia. Increases
20

-- 20 of 55 --

in crude oil prices unfavorably impact the cost of our products, as well as the cost of the transportation and distribution of our products. The length and severity
of the recent increases in the price of crude oil are highly unpredictable and may unfavorably impact our cost of goods sold for as long as these conditions exist.
Results of Operations
Three Months Ended November 30, 2022 Compared to Three Months Ended November 30, 2021
Operating Items
The following table summarizes operating data for our consolidated operations (in thousands, except percentages and per share amounts):
Three Months Ended November 30,
Change from
Prior Year
2022 	2021 	Dollars 	Percent
Net sales:
Maintenance products 	$ 	116,312 	$ 	126,030 	$ 	(9,718) 	(8)%
HCCP (1) 	8,581 	8,716 	(135) 	(2)%
Total net sales 	124,893 	134,746 	(9,853) 	(7)%
Cost of products sold 	60,638 	66,276 	(5,638) 	(9)%
Gross profit 	64,255 	68,470 	(4,215) 	(6)%
Operating expenses 	45,576 	44,410 	1,166 	3%
Income from operations 	$ 	18,679 	$ 	24,060 	$ 	(5,381) 	(22)%
Net income 	$ 	13,997 	$ 	18,555 	$ 	(4,558) 	(25)%
EPS – diluted 	$ 	1.02 	$ 	1.34 	$ 	(0.32) 	(24)%
Shares used in diluted EPS 	13,609 	13,752 	(143) 	(1)%
(1) Homecare and cleaning products (“HCCP”)
Net Sales by Segment
The following table summarizes net sales by segment (in thousands, except percentages):
Three Months Ended November 30,
Change from
Prior Year
2022 	2021 	Dollars 	Percent
Americas 	$ 	58,014 	$ 	56,288 	$ 	1,726 	3%
EMEA 	40,772 	57,555 	(16,783) 	(29)%
Asia-Pacific 	26,107 	20,903 	5,204 	25%
Total 	$ 	124,893 	$ 	134,746 	$ 	(9,853) 	(7)%
21

-- 21 of 55 --

Americas Sales
The following table summarizes net sales by product line for the Americas segment, which includes the U.S., Canada and Latin America (in thousands, except
percentages):
Three Months Ended November 30,
Change from
Prior Year
2022 	2021 	Dollars 	Percent
Maintenance products 	$ 	53,571 	$ 	51,984 	$ 	1,587 	3%
HCCP 	4,443 	4,304 	139 	3%
Total 	$ 	58,014 	$ 	56,288 	$ 	1,726 	3%
% of consolidated net sales 	46% 	42%
CC Net sales – non-GAAP (1) 	$ 	58,179 	$ 	56,288 	$ 	1,891 	3%
Currency impact on current period – non-GAAP 	$ 	(165)
(1) Current fiscal year constant currency (“CC”) net sales translated at the foreign currency exchange rates in effect for the corresponding period of the prior fiscal year, compared to prior
period actual net sales.
Increases in the average selling price of our products positively impacted net sales by approximately $13.6 million in the Americas segment, primarily due to
sales price increases implemented over the last twelve months. These favorable impacts were offset by a decrease in sales volume which unfavorably impacted
net sales by approximately $11.7 million from period to period. Changes to net sales attributable to volumes and the average selling price of our products are
impacted by differences in sales mix related to products, markets and distribution channels from period to period.
Americas Sales – Three Months Ended – November 30, 2022 Compared to November 30, 2021
Net sales of maintenance products in the Americas segment increased due to the following:
· United States (“U.S.”) sales increased $5.6 million, or 15%, primarily due to increased sales of WD-40 Specialist, WD-40 Multi-Use Product and 3-
IN-ONE products. WD-40 Specialist products are sourced at certain third-party manufacturers that were impacted significantly by global supply chain
constraints in the prior period. However, adjustments we have made in our supply chain to increase the production capacity of our most significant
products, including WD-40 Specialist, improved the availability of these products from period to period. WD-40 Specialist sales increased by $2.9
million, or 85%, primarily due to these improvements that resulted in increased sales volume, as well as price increases implemented during the last
twelve months. WD-40 Multi-Use Product sales increased by $1.6 million, or 5%, primarily due to price increases from period to period, as well as our
improved supply chain capacity. Although these price increases and improved supply chain capacity positively impacted sales of WD-40 Multi-Use
Product, the overall impact was significantly offset by a lower level of customer orders and promotional programs as customers adjust to the price
increases, which resulted in decreased sales volume. 3-IN-ONE product sales increased by $1.1 million, or 71%, primarily due to improved supply
chain capacity and price increases from period to period.
· Latin America sales decreased $4.1 million, or 31%, primarily due to the timing of marketing distributor orders from period to period. Sales were
unfavorably impacted due to marketing distributors purchasing a higher level of our product in advance of a price increase that went into effect in late
fiscal year 2022, which lowered purchases from these customers during the first quarter of fiscal year 2023. Conversely, sales in the first quarter of
fiscal year 2022 were favorably impacted due to significant purchase activity in advance of an earlier price increase that went into effect in November
2021.
· Canada sales remained relatively consistent period over period primarily due to the favorable impact of price increases which were mostly offset by
unfavorable changes in foreign currency exchanges rates and weaker economic conditions that resulted in lower levels of demand.
22

-- 22 of 55 --

Net sales of homecare and cleaning products in the Americas increased primarily due to the following:
· The favorable impact of price increases and the improvement in the capacity and flexibility of our supply chain, which were partially offset by lower
demand for certain brands from period to period.
· While each of our homecare and cleaning products have continued to generate positive cash flows, we have generally experienced flat or slightly
decreased sales for many of these products in recent periods.
For the three months ended November 30, 2022, 78% of sales came from the U.S., and 22% of sales came from Canada and Latin America combined compared
to the distribution for the three months ended November 30, 2021 when 70% of sales came from the U.S., and 30% of sales came from Canada and Latin
America.
EMEA Sales
The following table summarizes net sales by product line for the EMEA segment, which includes Europe, the Middle East, Africa and India (in thousands,
except percentages):
Three Months Ended November 30,
Change from
Prior Year
2022 	2021 	Dollars 	Percent
Maintenance products 	$ 	38,729 	$ 	55,443 	$ 	(16,714) 	(30)%
HCCP 	2,043 	2,112 	(69) 	(3)%
Total (1) 	$ 	40,772 	$ 	57,555 	$ 	(16,783) 	(29)%
% of consolidated net sales 	33% 	43%
CC Net sales – non-GAAP (2) 	$ 	48,787 	$ 	57,555 	$ 	(8,768) 	(15)%
Currency impact on current period – non-GAAP 	$ 	(8,015)
(1) While our reporting currency is the U.S. Dollar, the functional currency of our U.K. subsidiary, the entity in which the EMEA results are generated, is Pound Sterling. Although the
functional currency of this subsidiary is Pound Sterling, approximately 50% of its sales are generated in Euro and approximately 15% are generated in U.S. Dollar. As a result, the Pound
Sterling sales and earnings for the EMEA segment can be negatively or positively impacted from period to period upon translation from these currencies depending on whether the Euro and
U.S. Dollar are weakening or strengthening against the Pound Sterling.
(2) Current fiscal year constant currency net sales translated at the foreign currency exchange rates in effect for the corresponding period of the prior fiscal year, compared to prior period actual
net sales.
Increases in the average selling price of our products positively impacted net sales by approximately $9.5 million in the EMEA segment, primarily due to sales
price increases implemented over the last twelve months. These favorable impacts were more than offset by decreases in sales volume, which unfavorably
impacted net sales by approximately $18.3 million from period to period. Of this $18.3 million impact attributable to volume declines, $5.0 million relates to
our suspension of sales in Russia discussed below. Changes to net sales attributable to volumes and the average selling price of our products are impacted by
differences in sales mix related to products, markets and distribution channels from period to period. In addition, changes in foreign currency exchange rates
had an unfavorable impact of $8.0 million on net sales for the first quarter of fiscal year 2023.
The countries and regions in Europe where we sell through a direct sales force include the U.K., Italy, France, Iberia (which includes Spain and Portugal) and
the Germanics sales region (which includes Austria, Denmark, Switzerland, Belgium and the Netherlands). The regions in the EMEA segment where we sell
through local distributors include the Middle East, Africa, India, Eastern and Northern Europe.
23

-- 23 of 55 --

EMEA Sales – Three Months Ended – November 30, 2022 Compared to November 30, 2021
Net sales decreased in the EMEA segment primarily due to the following:
Direct Markets – EMEA (70% of net sales QTD FY2023 vs 63% QTD FY2022)
· Sales in our direct markets decreased $7.7 million, or 21%, primarily due to unfavorable changes in foreign currency exchanges rates of $5.7 million
as a result of the weakening of the Pound Sterling, the functional currency of our U.K. subsidiary, against the U.S. Dollar.
· Direct market sales also decreased due to lower levels of customer orders of maintenance products in France, Iberia, Germany, Italy and the United
Kingdom, partially offset by the favorable impact of price increases from period to period.
· In most direct markets, these volume decreases were due to reduced demand compared to the prior period, driven by weaker market and economic
conditions as well as a lower level of customer orders and promotional programs as customers adjust to these price increases implemented in late fiscal
year 2022 and first quarter of fiscal year 2023.
Marketing Distributors – EMEA (30% of net sales QTD FY2023 vs 37% QTD FY2022)
· Distributor market sales decreased $9.1 million, or 43%, in EMEA markets wherein we utilize a marketing distributor model (“distributor markets”), in
which products are sold to marketing distributors who in turn sell to wholesalers and retailers.
· Sales in Russia decreased $5.0 million from period to period due to the ongoing effects of the Russian military action in Ukraine. See The Impact of
Russian Military Action in Ukraine described in the “Significant Developments” section above for further information regarding the suspension of our
sales to Russian markets.
· In addition, sales in our distributor markets were unfavorably impacted by $2.3 million due to the weakening of the Pound Sterling, the functional
currency of our U.K. subsidiary, against the U.S. Dollar. However, this unfavorable impact to sales in distributor markets was partially offset by the
favorable impacts of certain sales denominated in currencies other than the Pound Sterling, which strengthened against the Pound Sterling from period
to period.
· Sales in distributor markets also decreased due to lower sales volumes of maintenance products in most distributor markets, particularly Poland and
India, which were down $1.1 million and $1.0 million, respectively.
· The decreases in distributor market sales were partially offset by price increases implemented over the last twelve months.
Asia-Pacific Sales
The following table summarizes net sales by product line for the Asia-Pacific segment, which includes Australia, China and other countries in the Asia region
(in thousands, except percentages):
Three Months Ended November 30,
Change from
Prior Year
2022 	2021 	Dollars 	Percent
Maintenance products 	$ 	24,012 	$ 	18,603 	$ 	5,409 	29%
HCCP 	2,095 	2,300 	(205) 	(9)%
Total 	$ 	26,107 	$ 	20,903 	$ 	5,204 	25%
% of consolidated net sales 	21% 	15%
CC Net sales – non-GAAP (1) 	$ 	27,469 	$ 	20,903 	$ 	6,566 	31%
Currency impact on current period – non-GAAP 	$ 	(1,362)
(1) Current fiscal year constant currency (“CC”) net sales translated at the foreign currency exchange rates in effect for the corresponding period of the prior fiscal year, compared to prior
period actual net sales.
24

-- 24 of 55 --

Increases in the average selling price of our products positively impacted net sales by approximately $3.1 million in the Asia-Pacific segment, primarily due to
sales price increases implemented over the last twelve months. In addition, an increase in sales volume favorably impacted net sales by approximately $3.5
million from period to period. Changes to net sales attributable to volumes and the average selling price of our products are impacted by differences in sales mix
related to products, markets and distribution channels from period to period. Changes in foreign currency exchange rates had an unfavorable impact of $1.4
million on net sales for the first quarter of fiscal year 2023.
Asia-Pacific Sales – Three Months Ended – November 30, 2022 Compared to November 30, 2021
Net sales in the Asia-Pacific segment increased primarily due to the following:
· Asia distributor markets sales increased $3.8 million, or 41%, primarily due to higher sales of WD-40 Multi-Use Product as a result of successful
promotional programs and the continued easing of COVID-19 lockdown measures, which resulted in increased demand and higher sales in most
countries in the region. In addition, net sales increased due to the favorable impact of price increases from period to period, as well as customers
purchasing product in advance of anticipated additional price increases.
· China sales increased $1.3 million, or 22%, due to the success of promotional programs in the first quarter of fiscal year 2023. Sales were also
favorably impacted by the timing of shipments related to customer orders placed in late fiscal year 2022 resulting from a successful promotional
program in that fiscal year; certain products related to these orders were not shipped until early fiscal year 2023. In addition, net sales increased due to
the favorable impacts of price increases. These favorable impacts were partially offset by unfavorable changes in foreign currency exchange rates. On
a constant currency basis, sales in China would have increased $2.0 million, or 34%.
· Australia sales remained consistent from period to period, as the favorable impact of price increases was almost completely offset by the unfavorable
impact of changes in foreign currency exchange rates and decreased sales levels of homecare and cleaning products. On a constant currency basis,
sales in Australia would have increased $0.7 million, or 12%.
Gross Profit
The following general information regarding the timing and nature of our product costs is important when assessing fluctuations in our gross margin from
period to period:
· There is often a delay of one quarter or more before changes in costs of raw materials, such as specialty chemicals used in the formulation of our products,
impact cost of products sold due to production and inventory life cycles;
· In general, the timing of advertising, promotional and other discounts may cause fluctuations in gross margin from period to period. Advertising,
promotional and other discounts that are given to our customers are recorded as a reduction to sales, whereas advertising and sales promotional costs
associated with promotional activities that we pay to third parties are recorded as advertising and sales promotion expenses;
· In the EMEA segment, the majority of our cost of goods sold is denominated in Pound Sterling whereas sales are generated in Pound Sterling, Euro and the
U.S. Dollar. The strengthening or weakening of the Euro and U.S. Dollar against the Pound Sterling may result in foreign currency related changes to the
gross margin percentage in the EMEA segment from period to period; and
· Our gross profit and gross margin may not be comparable to those of other consumer product companies, since some of these companies include all costs
related to distribution of their products in cost of products sold, whereas we exclude the portion associated with amounts paid to third parties for shipment to
our customers from our distribution centers and contract manufacturers and include these costs in selling, general and administrative expenses. These costs
totaled $4.2 million and $4.8 million for the three months ended November 30, 2022 and 2021, respectively.
· For further information pertaining to recent trends and economic conditions affecting gross margin, please see the section titled “Significant Developments”.
25

-- 25 of 55 --

The following table summarizes gross margin and gross profit (in thousands, except percentages):
Three Months Ended November 30,
2022 	2021
Change from
Prior Year
Gross profit 	$ 	64,255 	$ 	68,470 	$ 	(4,215)
Gross margin 	51.4% 	50.8% 	60 	bps (1)
(1) Basis points (“bps”) change in gross margin.
Gross Margin - Three Months Ended – November 30, 2022 Compared to November 30, 2021
Gross margin increased 60 bps primarily due to the following favorable impacts, partially offset by unfavorable impacts:
Favorable/(Unfavorable) 	Explanations
860 bps 	Sales price increases implemented in all three segments at varying times during the last twelve months.
90 bps 	Changes in foreign currency exchange rates in the EMEA segment.
60 bps 	Favorable sales mix and other miscellaneous mix impacts
(360) bps 	Higher costs of aerosol cans.
(330) bps 	Higher costs of specialty chemicals used in the formulation of our products.
(120) bps 	Increases in miscellaneous other input costs.
(100) bps 	Higher filling fees paid to our third-party contract manufacturers, primarily in the Americas segment.
(80) bps 	Higher warehousing, distribution and freight costs associated with supply chain constraints as a result of the ongoing COVID-19
pandemic, the worsening inflationary environment and initiatives to increase production capacity while these constraints exist.
Selling, General and Administrative (“SG&A”) Expenses
Three Months Ended November 30,
Change from
Prior Year
(in thousands) 	2022 	2021 	Dollars 	Percent
SG&A expenses 	$ 	39,984 	$ 	38,423 	$ 	1,561 	4%
% of net sales 	32.0% 	28.5%
SG&A Expenses – Three Months Ended – November 30, 2022 Compared to November 30, 2021
The increase in SG&A expenses was primarily due to increases in travel and meeting expense of $2.1 million due to the reduction in travel restrictions related
to COVID-19 from period to period, resulting in a higher level of travel and meetings by employees. In addition, employee-related costs increased by $1.0
million due increased headcount and annual compensation increases, which was partially offset by lower incentive compensation accruals. In addition,
professional services fees increased $0.8 million in support of our strategic initiatives in the Americas and EMEA segments, as well as the ongoing
implementation of our new information system and increased cloud-based software usage and license fees. Other miscellaneous expenses also increased $0.5
million from period to period. These increases to SG&A expenses were partially offset by changes in foreign currency exchange rates from period to period
resulting in a decrease of $2.8 million in SG&A expenses.
We continued our research and development investment, the majority of which is associated with our maintenance products, in support of our focus on
innovation and renovation of our products. Research and development costs were $1.3 million for both the three months ended November 30, 2022 and 2021.
Our research and development team engages in consumer research, product development, current product improvements and testing activities. This team
leverages its development capabilities by collaborating with a network of outside resources including our current and prospective third-party contract
26

-- 26 of 55 --

manufacturers. The level and types of expenses incurred within research and development can vary from period to period depending upon the types of activities
being performed.
Advertising and Sales Promotion (“A&P”) Expenses
Three Months Ended November 30,
Change from
Prior Year
(in thousands) 	2022 	2021 	Dollars 	Percent
A&P expenses 	$ 	5,339 	$ 	5,624 	$ 	(285) 	(5)%
% of net sales 	4.3% 	4.2%
A&P Expenses – Three Months Ended – November 30, 2022 Compared to November 30, 2021
Although A&P expenses decreased from period to period, A&P expenses as a percentage of net sales remained relatively constant. The decrease in A&P
expenses was primarily due to favorable changes in foreign currency exchange currency from period to period of $0.5 million primarily in the EMEA segment.
As a percentage of net sales, A&P expenses may fluctuate period to period based upon the type of marketing activities we employ and the period in which the
costs are incurred. Total promotional costs recorded as a reduction to sales was $6.5 million and $6.9 million for three months ended November 30, 2022 and
2021, respectively. Therefore, our total investment in A&P activities totaled $11.8 million and $12.5 million for the three months ended November 30, 2022 and
2021, respectively.
Income from Operations by Segment
The following table summarizes income from operations by segment (in thousands, except percentages):
Three Months Ended November 30,
Change from
Prior Year
2022 	2021 	Dollars 	Percent
Americas 	$ 	12,772 	$ 	12,017 	$ 	755 	6%
EMEA 	6,283 	14,213 	(7,930) 	(56)%
Asia-Pacific 	9,617 	7,302 	2,315 	32%
Unallocated corporate 	(9,993) 	(9,472) 	(521) 	(6)%
Total 	$ 	18,679 	$ 	24,060 	$ 	(5,381) 	(22)%
Americas
Americas Operating Income – Three Months Ended – November 30, 2022 Compared to November 30, 2021
Income from operations for the Americas increased to $12.8 million, up $0.8 million, or 6%, due to a $1.7 million increase in sales and a higher gross margin,
partially offset by higher operating expenses. Gross margin for the Americas segment increased from 48.7% to 50.7% primarily due to the favorable impact of
price increases over the last twelve months, offset by increases in the costs of petroleum-based specialty chemicals, aerosol cans and filling fees at our third-
party manufacturers due to inflationary impacts. In addition, higher warehousing, distribution and freight costs unfavorably impacted gross margin. The
increase in operating expenses from period to period was primarily due to higher travel and meeting expense, as well as higher salary and other employee costs,
offset by lower incentive compensation accruals. Operating income as a percentage of net sales increased from 21.3% to 22.0% period over period.
27

-- 27 of 55 --

EMEA
EMEA Operating Income – Three Months Ended – November 30, 2022 Compared to November 30, 2021
Income from operations for the EMEA segment decreased to $6.3 million, down $7.9 million, or 56%, primarily due to a $16.8 million decrease in sales and
lower gross margin, partially offset by a decrease in operating expenses. Gross margin for the EMEA segment decreased from 51.5% to 50.6% primarily due to
the combined unfavorable impacts of fluctuations in foreign currency exchange rates and the increased costs of aerosol cans and petroleum-based specialty
chemicals. In addition, gross margin was also unfavorably impacted by increases in discounts provided to our customers, as well as increased warehousing,
distribution and freight costs, due to supply chain constraints and inflationary impacts. These unfavorable impacts to gross margin were significantly offset by
price increases that were implemented over the last twelve months. Operating expenses decreased $1.1 million primarily due to lower A&P expenses, and lower
accrued incentive compensation, as well as lower freight costs as a result of lower sales volumes. Operating income as a percentage of net sales decreased from
24.7% to 15.4% period over period.
Asia-Pacific
Asia-Pacific Operating Income – Three Months Ended – November 30, 2022 Compared to November 30, 2021
Income from operations for the Asia-Pacific segment increased to $9.6 million, up $2.3 million, or 32%, primarily due to a $5.2 million increase in sales,
partially offset by an increase in operating expenses. Gross margin for the Asia-Pacific segment decreased slightly from 54.5% to 54.4% primarily due to the
unfavorable impacts of increases to the cost of petroleum-based specialty chemicals and fluctuations in foreign currency exchange rates. These unfavorable
impacts to gross margin were almost completely offset by price increases that were implemented during the last twelve months. Operating expenses increased
$0.5 million from period to period primarily due to higher A&P expenses and higher miscellaneous expenses. Operating income as a percentage of net sales
increased from 34.9% to 36.8% period over period.
Non-Operating Items
The following table summarizes non-operating income and expenses for our consolidated operations (in thousands):
Three Months Ended November 30,
2022 	2021 	Change
Interest income 	$ 	44 	$ 	25 	$ 	19
Interest expense 	$ 	1,169 	$ 	620 	$ 	549
Other income (expense), net 	$ 	150 	$ 	(329) 	$ 	479
Provision for income taxes 	$ 	3,707 	$ 	4,581 	$ 	(874)
Interest Income
Interest income was not significant during the three months ended November 30, 2022 and 2021.
Interest Expense
Interest expense increased $0.5 million for the three months ended November 30, 2022 compared to the corresponding period of the prior fiscal year primarily
due to higher aggregate outstanding balances on our revolving credit agreement from period over period and changes in interest rates.
Other Income (Expense), Net
Other income (expense), net was not significant during the three months ended November 30, 2022 and 2021. Other income (expense), net changed by $0.5
million for the three months ended November 30, 2022 compared to the corresponding period of the prior fiscal year primarily due to fluctuations in the foreign
currency exchange rates for both the U.S. Dollar and the Euro against the Pound Sterling.
28

-- 28 of 55 --

Provision for Income Taxes
The provision for income taxes was 20.9% and 19.8% of income before income taxes for the three months ended November 30, 2022 and 2021, respectively.
The increase in the effective income tax rate from period to period was primarily due to tax shortfalls from the settlements of stock-based equity awards,
partially offset by a one-time tax-deductible charitable donation. The Company recorded tax shortfalls related to settlements of stock-based equity awards of
$0.7 million during the first quarter of fiscal year 2023 compared to insignificant tax benefits related to these types of settlements in the first quarter of fiscal
year 2022, resulting in a 5.1% unfavorable impact on the Company’s effective tax rate from period to period. Partially offsetting this unfavorable impact was a
one-time tax benefit associated with the Company’s donation of its former corporate headquarters building to a local San Diego community foundation that
occurred in the first quarter of fiscal year 2023, resulting in a 4.2% favorable impact on the Company’s effective tax rate. The building, net of its tax basis, is
estimated to result in a charitable donation of $3.5 million and an approximate tax benefit of $0.7 million.
Net Income
Net income was $14.0 million, or $1.02 per common share on a fully diluted basis, for the three months ended November 30, 2022 compared to $18.6 million,
or $1.34 per common share on a fully diluted basis, for the corresponding period of the prior fiscal year. Changes in foreign currency exchange rates from
period to period had an unfavorable impact of $1.3 million on consolidated net income for the first quarter of fiscal year 2023. Thus, on a constant currency
basis, net income would have decreased $3.3 million, or 18%, from period to period.
Performance Measures and Non-GAAP Reconciliations
In managing our business operations and assessing our financial performance, we supplement the information provided by our financial statements with certain
non-GAAP performance measures. These performance measures are part of our current 55/30/25 business model, which includes gross margin, cost of doing
business, and earnings before interest, income taxes, depreciation and amortization (“EBITDA”), the latter two of which are non-GAAP performance measures.
Cost of doing business is defined as total operating expenses less amortization of definite-lived intangible assets, impairment charges related to intangible
assets and depreciation in operating departments, and EBITDA is defined as net income before interest, income taxes, depreciation and amortization. We target
our gross margin to be at or above 55% of net sales, our cost of doing business to be at 30% of net sales, and our EBITDA to be at or above 25% of net sales.
Results for these performance measures may vary from period to period depending on various factors, including economic conditions and our level of
investment in activities for the future such as those related to quality assurance, regulatory compliance, and intellectual property protection in order to safeguard
our WD-40 brand. Our financial results and operations continue to be impacted by increased global supply chain constraints and an inflationary environment,
both of which have significantly lowered our gross margin percentage over the last twelve months and moved us well below our target of 55%. Although we
have been implementing strategic sales price increases across all segments at varying times in response to increased costs, it will take time before the full
impact of these sales price increases are reflected in our reported results. In addition, it is difficult to determine how long these supply chain and inflationary
conditions will exist and if they will worsen or improve over time. However, the targets for gross margin and these other performance measures are long-term in
nature and we expect to make progress towards achieving them over time. For more detailed information pertaining to recent trends and economic conditions
and the actions we are taking to respond to them, please see the section titled “Significant Developments”.
The following table summarizes the results of these performance measures:
Three Months Ended November 30,
2022 	2021
Gross margin – GAAP 	51% 	51%
Cost of doing business as a percentage
of net sales – non-GAAP 	36% 	32%
EBITDA as a percentage of net sales – non-GAAP (1) 	17% 	19%
(1) Percentages may not aggregate to EBITDA percentage due to rounding and because amounts recorded in other income (expense), net on our consolidated statement of operations are not
included as an adjustment to earnings in the EBITDA calculation.
29

-- 29 of 55 --

We use the performance measures above to establish financial goals and to gain an understanding of our comparative performance from period to period. We
believe that these measures provide our stockholders with additional insights into how we run our business. We believe these measures also provide investors
with additional financial information that should be considered when assessing our underlying business performance and trends. These non-GAAP financial
measures are supplemental in nature and should not be considered in isolation or as alternatives to net income, income from operations or other financial
information prepared in accordance with GAAP as indicators of our performance or operations. The use of any non-GAAP measure may produce results that
vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies. Reconciliations of these non-
GAAP financial measures to our financial statements as prepared in accordance with GAAP are as follows:
Cost of Doing Business (in thousands, except percentages)
Three Months Ended November 30,
2022 	2021
Total operating expenses – GAAP 	$ 	45,576 	$ 	44,410
Amortization of definite-lived intangible assets 	(253) 	(363)
Depreciation (in operating departments) 	(965) 	(1,098)
Cost of doing business 	$ 	44,358 	$ 	42,949
Net sales 	$ 	124,893 	$ 	134,746
Cost of doing business as a percentage
of net sales – non-GAAP 	36% 	32%
EBITDA (in thousands, except percentages)
Three Months Ended November 30,
2022 	2021
Net income – GAAP 	$ 	13,997 	$ 	18,555
Provision for income taxes 	3,707 	4,581
Interest income 	(44) 	(25)
Interest expense 	1,169 	620
Amortization of definite-lived intangible assets 	253 	363
Depreciation 	1,643 	1,623
EBITDA 	$ 	20,725 	$ 	25,717
Net sales 	$ 	124,893 	$ 	134,746
EBITDA as a percentage of net sales – non-GAAP 	17% 	19%
Liquidity and Capital Resources
Overview
Our financial condition and liquidity remain strong. Although there continues to be uncertainty related to the ongoing and anticipated impact of the COVID-19
pandemic and inflationary environment on our future results, we believe our efficient business model and the steps that we have taken position us to manage our
business through the situation as it continues to develop. We continue to manage all aspects of our business including, but not limited to, monitoring our
liquidity, the financial health of our customers, suppliers and other third-party relationships, implementing gross margin enhancement strategies and developing
new opportunities for growth.
Our principal sources of liquidity are cash generated from operations and cash currently available from our existing unsecured revolving credit facility under the
Credit Agreement with Bank of America. We use proceeds of the revolving credit facility
30

-- 30 of 55 --

primarily for our general working capital needs. We also hold borrowings under the Note Agreement. See Note 7 – Debt for additional information on these
agreements.
We have historically held a balance of outstanding draws on our line of credit in either U.S. Dollars in the Americas segment, or in Euros and Pound Sterling in
the EMEA segment. Euro and Pound Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency
exchange rates. We regularly convert many of our draws on our line of credit to new draws with new maturity dates and interest rates. We have the ability to
refinance any draws under the line of credit with successive short-term borrowings through the September 30, 2025 maturity date of the Credit Agreement.
Outstanding draws for which we have both the ability and intent to refinance with successive short-term borrowings for a period of at least twelve months are
classified as long-term. As of November 30, 2022, $40.7 million of the outstanding balance under our line of credit resides in the EMEA segment and is
denominated in Euros and Pounds Sterling and classified long-term, whereas $41.7 million is denominated in U.S. Dollars and classified as short-term. In the
United States, we held $68.0 million in fixed rate long-term borrowings as of November 30, 2022, consisting of senior notes under our Note Agreement. We
paid $0.4 million in principal payments on our Series A Notes during the first three months of fiscal year 2023. There were no other letters of credit outstanding
or restrictions on the amount available on our line of credit or notes. Per the terms of both the Note Agreement and the Credit Agreement, our consolidated
leverage ratio cannot be greater than three and a half to one and our consolidated interest coverage ratio cannot be less than three to one. See Note 7 – Debt for
additional information on these financial covenants. At November 30, 2022, we were in compliance with all material debt covenants. We continue to monitor
our compliance with all debt covenants and, at the present time, we believe that the likelihood of being unable to satisfy all material covenants is remote. At
November 30, 2022, we had a total of $36.9 million in cash and cash equivalents. We do not foresee any ongoing issues with repaying our borrowings and we
closely monitor the use of this credit facility.
We believe that our future cash from domestic and international operations, together with our access to funds available under our unsecured revolving credit
facility, will provide adequate resources to fund short-term and long-term operating requirements, capital expenditures, dividend payments, acquisitions, new
business development activities and share repurchases. On October 12, 2021, our Board of Directors approved a new share repurchase plan. Under the plan,
which became effective on November 1, 2021, we are authorized to acquire up to $75.0 million of our outstanding shares through August 31, 2023, of which
$41.8 million remains available for the repurchase of shares of common stock as of November 30, 2022.
Cash Flows
The following table summarizes our cash flows by category for the periods presented (in thousands):
Three Months Ended November 30,
2022 	2021 	Change
Net cash provided by (used in) operating activities 	$ 	10,437 	$ 	(947) 	$ 	11,384
Net cash used in investing activities 	(1,300) 	(2,362) 	1,062
Net cash used in financing activities 	(12,342) 	(21,937) 	9,595
Effect of exchange rate changes on cash and cash equivalents 	2,244 	(1,196) 	3,440
Net decrease in cash and cash equivalents 	$ 	(961) 	$ 	(26,442) 	$ 	25,481
Operating Activities
Net cash provided by operating activities was $10.4 million for the three months ended November 30, 2022 compared to net cash used in operating activities of
$0.9 million for the prior period resulting in a net change of $11.4 million. Cash flows from operating activities depend heavily on operating performance and
changes in working capital. Our primary source of operating cash flows for the three months ended November 30, 2022 was net income of $14.0 million, which
decreased approximately $4.6 million from period to period.
Changes in our working capital, which increased net cash provided by operating activities was primarily attributable to decreases in trade accounts receivable
balances during the first three months of the fiscal year compared to increases in trade accounts receivable during the first three months of the prior fiscal year.
This was primarily due to a decrease in sales from
31

-- 31 of 55 --

period to period. In addition, net cash provided by operating activities increased due to lower earned incentive payouts in the first quarter of fiscal year 2023
compared to the same period of the prior fiscal year as well as decreases in other current assets from period to period primarily due to a lower income tax
receivable balance, as well as lower deposits and miscellaneous prepaid expenses. These changes were partially offset by decreases in accounts payable and
accrued liabilities balances during the first three months of the fiscal year compared to increases in accounts payable and accrued liabilities during the first three
months of the prior fiscal year.
Investing Activities
Net cash used in investing activities decreased $1.1 million to $1.3 million for the three months ended November 30, 2022, primarily due to a lower level of
manufacturing-related capital expenditures within the United States and the United Kingdom from period to period.
Financing Activities
Net cash used in financing activities decreased $9.6 million to $12.3 million for the three months ended November 30, 2022. This change was primarily due to
decreases in shares withheld to cover taxes on conversion of equity rewards of $3.6 million primarily due to lower settlements of stock-based equity awards
from period to period. Additionally, cash used in financing activities was decreased by proceeds provided by our autoborrow agreement of $3.4 million during
the first three months of the fiscal year, whereas no draws were made on our autoborrow agreement in the corresponding period of the prior fiscal year. In
addition, treasury stock purchases decreased by $3.3 million. Offsetting these decreases in cash outflows from period to period were increases in dividends paid
to our stockholders of $0.7 million.
Effect of Exchange Rate Changes
All of our foreign subsidiaries currently operate in currencies other than the U.S. Dollar and a significant portion of our consolidated cash balance is
denominated in these foreign functional currencies, particularly at our U.K. subsidiary, which operates in Pound Sterling. As a result, our cash and cash
equivalents balances are subject to the effects of the fluctuations in these functional currencies against the U.S. Dollar at the end of each reporting period. The
net effect of exchange rate changes on cash and cash equivalents, when expressed in U.S. Dollar terms, was an increase in cash of $2.2 million for the three
months ended November 30, 2022 as compared to a decrease in cash of $1.2 million for the three months ended November 30, 2021. These changes were
primarily due to fluctuations in various foreign currency exchange rates from period to period, but the majority is related to the fluctuations in the Pound
Sterling against the U.S. Dollar.
Commercial Commitments
We have ongoing relationships with various third-party suppliers (contract manufacturers) that manufacture our products and third-party distribution centers
which warehouse and ship our products to customers. The contract manufacturers maintain title and control of certain raw materials and components, materials
utilized in finished products, and of the finished products themselves until shipment to our customers or third-party distribution centers in accordance with
agreed upon shipment terms. Although we have definitive minimum purchase obligations in the contract terms with certain of our contract manufacturers, when
such obligations have been included, they have either been immaterial or the minimum amounts have been such that they are well below the volume of goods
that we have historically purchased. In addition, in the ordinary course of business, we communicate supply needs to our contract manufacturers based on
orders and short-term projections, ranging from two to six months. We are committed to purchase the products produced by the contract manufacturers based on
the projections provided.
Upon the termination of contracts with contract manufacturers, we obtain certain inventory control rights and are obligated to work with the contract
manufacturer to sell through all product held by or manufactured by the contract manufacturer on our behalf during the termination notification period. If any
inventory remains at the contract manufacturer at the termination date, we are obligated to purchase such inventory, which may include raw materials,
components and finished goods. The amounts for inventory purchased under termination commitments have been immaterial.
In addition to the commitments to purchase products from contract manufacturers described above, we may also enter into commitments with other
manufacturers to purchase finished goods and components to support innovation initiatives and/or supply chain initiatives. As of November 30, 2022, no such
commitments were outstanding.
32

-- 32 of 55 --

Share Repurchase Plan
The information required by this item is incorporated by reference to Part I—Item 1, “Notes to Condensed Consolidated Financial Statements” Note 8 — Share
Repurchase Plan, included in this report.
Dividends
On December 13, 2022, the Company’s Board approved a 6% increase in the regular quarterly cash dividend, increasing it from $0.78 per share to $0.83 per
share. The $0.83 per share dividend declared on December 13, 2022 is payable on January 31, 2023 to stockholders of record on January 13, 2023.
Critical Accounting Policies and Estimates
Our discussion and analysis of our operating results and financial condition is based upon our consolidated financial statements, which have been prepared in
accordance with generally accepted accounting principles in the United States of America.
Critical accounting policies are those that involve subjective or complex judgments, often as a result of the need to make estimates. The following areas all
require the use of judgments and estimates: revenue recognition, accounting for income taxes and impairment of definite-lived intangible assets. Estimates in
each of these areas are based on historical experience and various judgments and assumptions that we believe are appropriate. Actual results may differ
materially from these estimates.
There have been no material changes in our critical accounting policies and estimates from those disclosed in Part II―Item 7, “Management’s Discussion and
Analysis of Financial Condition and Results of Operations,” and Note 2 to our consolidated financial statements contained in our Annual Report on Form 10-K
for the fiscal year ended August 31, 2022, which was filed with the SEC on October 24, 2022.
Recently Issued Accounting Standards
There have been no recently issued accounting standards that will have a material impact on our consolidated financial statements and related disclosures.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
The information required by this item is incorporated by reference to Part II―Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our
Annual Report on Form 10-K for the fiscal year ended August 31, 2022, which was filed with the SEC on October 24, 2022.
Item 4. Controls and Procedures
The term “disclosure controls and procedures” is defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as
amended (“Exchange Act”). The term disclosure controls and procedures means controls and other procedures of a company that are designed to ensure the
information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and
communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as
appropriate to allow timely decisions regarding required disclosures. The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the
effectiveness of the Company’s disclosure controls and procedures as of November 30, 2022, the end of the period covered by this report (the Evaluation Date),
and they have concluded that, as of the Evaluation Date, such controls and procedures were effective at ensuring that required information will be disclosed on a
timely basis in the Company’s reports filed under the Exchange Act. Although management believes the Company’s existing disclosure controls and procedures
are adequate to enable the Company to comply with its disclosure obligations, management continues to review and update such controls and
33

-- 33 of 55 --

procedures. The Company has a disclosure committee, which consists of certain members of the Company’s senior management.
There were no changes in our internal control over financial reporting during the three months ended November 30, 2022 that materially affected, or are
reasonably likely to materially affect, the Company’s internal control over financial reporting.
34

-- 34 of 55 --

PART II — OTHER INFORMATION
Item 1. Legal Proceedings
The information required by this item is incorporated by reference to the information set forth in Part I—Item 1, “Notes to Condensed Consolidated Financial
Statements” Note 11 — Commitments and Contingencies, included in this report.
Item 1A. Risk Factors
There have been no material changes in our risk factors from those disclosed in Part I—Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the
fiscal year ended August 31, 2022, which was filed with the SEC on October 24, 2022. The risks described in our Annual Report are not the only risks facing
our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, could also materially adversely affect
our operating results, financial condition or future business.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On October 12, 2021, the Company’s Board of Directors approved a new share repurchase plan. Under the plan, which became effective on November 1, 2021,
the Company is authorized to acquire up to $75.0 million of its outstanding shares through August 31, 2023. The timing and amount of repurchases are based on
terms and conditions as may be acceptable to the Company’s Chief Executive Officer and Chief Financial Officer, subject to present loan covenants and in
compliance with all laws and regulations applicable thereto. During the period from September 1, 2022 through November 30, 2022, the Company repurchased
22,420 shares at a total cost of $4.1 million under this $75.0 million plan.
The following table provides information with respect to all purchases made by the Company during the three months ended November 30, 2022. All purchases
listed below were made in the open market at prevailing market prices. Purchase transactions during the first quarter of fiscal year 2023 were executed pursuant
to trading plans adopted by the Company pursuant to Rule 10b5-1 and Rule 10b-18 under the Securities Exchange Act of 1934.
Total Shares Purchased 	Max $ Value of Shares
as Part of Publicly 	That May Yet Be
Total # of Shares 	Average Price Paid 	Announced Plans 	Purchased Under the
Purchased 	Per Share 	& Programs 	Plans & Programs
Period
September 1 – September 30 	12,400 	$ 	184.69 	12,400 	$ 	43,554,173
October 1 – October 31 	10,020 	$ 	177.79 	10,020 	$ 	41,772,561
November 1 – November 30 	- 	$ 	- 	- 	$ 	41,772,561
22,420 	$ 	181.60 	22,420
35

-- 35 of 55 --

Item 6. Exhibits
Exhibit No. 	Description
3(a) 	Certificate of Incorporation, incorporated by reference from the Registrant’s Form 10-K filed October 21, 2020, Exhibit 3(a) thereto.
3(b) 	Amended and Restated Bylaws of WD-40 Company, incorporated by reference from the Registrant’s Form 8-K filed August 16,
2018, Exhibit 3.1 thereto.
10(a) 	Form of Change in Control Severance Agreement between WD-40 Company and Executive Officers.
31(a) 	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31(b) 	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32(a) 	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32(b) 	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 	The following materials from WD-40 Company’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2022, formatted in iXBRL
(inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of
Operations; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’
Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) Notes to the Condensed Consolidated Financial Statements.
104 	The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101.
36

-- 36 of 55 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
WD-40 COMPANY
Registrant
Date: January 9, 2023 	By: 	/s/ STEVEN A. BRASS
Steven A. Brass
President and Chief Executive Officer
(Principal Executive Officer)
By: 	/s/ SARA K. HYZER
Sara K. Hyzer
Vice President, Finance
Treasurer and Chief Financial Officer
By: 	/s/ RAE ANN PARTLO
Rae Ann Partlo
Vice President, Corporate Controller and
Principal Accounting Officer
37

-- 37 of 55 --

Exhibit 10(a)
AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT
THIS AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT
(“Agreement”) is made as of the __ day of _________, 20__ (the “Effective Date”), between WD-40
COMPANY (hereinafter the “Company”) and _________ (hereinafter the “Executive”).
RECITALS:
WHEREAS, the Company has determined that the Executive is among that group of key
managers whose services and participation in management may be critical in any period of transition,
such as at the time of any change in control of the Company or in the face of any proposed corporate
reorganization or acquisition, friendly or hostile, affecting the Company;
WHEREAS, the board of directors of the Company (the “Board”) has determined that it is
appropriate and in the best interests of the Company and its stockholders that provisions be made to
encourage the Executive’s continued attention and undistracted dedication to the Executive’s duties in
the potentially disturbing circumstances of a possible change in control of the Company, by providing
the Executive with some degree of personal financial security under such circumstances;
WHEREAS, the Company and Executive are parties to that certain Change of Control
Severance Agreement dated as of _________ (the “Prior Agreement”); and
WHEREAS, the parties desire to amend and restate the Prior Agreement on the terms set forth
herein.
NOW THEREFORE, the parties agree as follows:
1. 	Change in Control. For purposes of this Agreement, “Change in Control” shall mean:
(a) 	the acquisition by any individual, entity or group (within the meaning of
Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”)) (a “Person”), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of 30% or more of either (i) the then-outstanding shares of common stock of the
Company (the “Outstanding Company Common Stock”) or (ii) the combined voting power of the then-
outstanding voting securities of the Company entitled to vote generally in the election of directors (the
“Outstanding Company Voting Securities”); provided, however, that the following acquisitions shall
not constitute a Change in Control: (A) any acquisition directly from the Company (excluding an
acquisition by virtue of the exercise of a conversion privilege), (B) any acquisition by any employee
benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled
by the Company or (C) any acquisition by any corporation
1

-- 38 of 55 --

pursuant to a reorganization, merger or consolidation, if, following such reorganization, merger or
consolidation, the conditions described in subclauses (i), (ii) and (iii) of subparagraph (c) of this
sentence are satisfied; or
(b) 	if individuals who, as of the date hereof, constitute the Board (the
“Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided,
however, that any individual becoming a director subsequent to the date hereof whose election, or
nomination for election by the Company’s stockholders, was approved by a vote of at least two-thirds
of the directors then constituting the Incumbent Board shall be considered as though such individual
were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose
initial assumption of office occurs as a result of either an actual or threatened election contest subject to
Rule 14a-11 of Regulation 14A promulgated under the Exchange Act or other actual or threatened
solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(c) 	a reorganization, merger or consolidation, unless following such
reorganization, merger or consolidation (i) more than 60% of, respectively, the then-outstanding shares
of common stock of the corporation resulting from such reorganization, merger or consolidation and
the combined voting power of the then outstanding voting securities of such corporation entitled to
vote generally in the election of directors is then beneficially owned, directly or indirectly, by all or
substantially all of the individuals and entities who were the beneficial owners, respectively, of the
Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior
to such reorganization, merger, or consolidation in substantially the same proportions as their
ownership, immediately prior to such reorganization, merger or consolidation, of the Outstanding
Company Common Stock and Outstanding Company Voting Securities, as the case may be (for
purposes of determining whether such percentage test is satisfied, there shall be excluded from the
number of shares and voting securities of the resulting corporation owned by the Company’s
stockholders, but not from the total number of outstanding shares and voting securities of the resulting
corporation, any shares or voting securities received by any such stockholder in respect of any
consideration other than shares or voting securities of the Company); (ii) no Person (excluding the
Company, any employee benefit plan (or related trust) of the Company, any qualified employee benefit
plan of such corporation resulting from such reorganization, merger or consolidation and any Person
beneficially owning, immediately prior to such reorganization, merger or consolidation, directly or
indirectly, 20% or more of the Outstanding Company Common Stock or Outstanding Company Voting
Securities, as the case may be) beneficially owns, directly or indirectly, 30% or more of, respectively,
the then-outstanding shares of common stock of the corporation resulting from such reorganization,
merger or consolidation or the combined voting power of the then-outstanding voting securities of such
corporation entitled to vote generally in the election of directors; and (iii) at least a majority of the
members of the board of directors of the corporation resulting from such reorganization, merger or
consolidation were members of the Incumbent Board at the time of the execution of the initial
agreement providing for such reorganization, merger or consolidation; or
(d)(i) approval by the stockholders of the Company of a complete liquidation or
dissolution of the Company or (ii) the first to occur of (A) the sale or other disposition (in one
transaction or a series of related transactions) of all or substantially all of the assets of the
2

-- 39 of 55 --

Company, or (B) the approval by the stockholders of the Company of any such sale or disposition,
other than, in each case, any such sale or disposition to a corporation, with respect to which
immediately thereafter, (1) more than 60% of, respectively, the then-outstanding shares of common
stock of such corporation and the combined voting power of the then-outstanding voting securities of
such corporation entitled to vote generally in the election of directors is then beneficially owned,
directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial
owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting
Securities immediately prior to such sale or other disposition in substantially the same proportion as
their ownership, immediately prior to such sale or other disposition, of the Outstanding Company
Common Stock and Outstanding Company Voting Securities, as the case may be (for purposes of
determining whether such percentage test is satisfied, there shall be excluded from the number of
shares and voting securities of the transferee corporation owned by the Company’s stockholders, but
not from the total number of outstanding shares and voting securities of the transferee corporation, any
shares or voting securities received by any such stockholder in respect of any consideration other than
shares or voting securities of the Company); (2) no Person (excluding the Company, any employee
benefit plan (or related trust) of the Company, any qualified employee benefit plan of such transferee
corporation and any Person beneficially owning, immediately prior to such sale or other disposition,
directly or indirectly, 20% or more of the Outstanding Company Common Stock or Outstanding
Company Voting Securities, as the case may be) beneficially owns, directly or indirectly, 30% or more
of, respectively, the then-outstanding shares of common stock of such transferee corporation and the
combined voting power of the then-outstanding voting securities of such transferee corporation entitled
to vote generally in the election of directors; and (3) at least a majority of the members of the board of
directors of such transferee corporation were members of the Incumbent Board at the time of the
execution of the initial agreement or action of the board providing for such sale or other disposition of
assets of the Company.
Notwithstanding the foregoing, if a Change in Control would give rise to a payment or
settlement event with respect to any payment or benefit under this Agreement that constitutes
“nonqualified deferred compensation,” the transaction or event constituting the Change in Control must
also constitute a “change in control event” (as defined in Treasury Regulation Section 1.409A-3(i)(5))
in order to give rise to the payment or settlement event for such payment or benefit, to the extent
required by Section 409A.
2. 	Termination Following a Change in Control.
(a) 	The Executive shall be entitled to the compensation provided for in
Paragraph 3 if all of the following conditions are satisfied:
(i) 	there is a Change in Control of the Company while the
Executive is still an employee of the Company;
(ii) 	the Executive’s employment with the Company is
terminated within two years after the Change in Control; and
3

-- 40 of 55 --

(iii) 	the Executive’s termination of employment is not a result
of (A) the Executive’s death; (B) the Executive’s Disability (as defined in subparagraph 2(b) below);
(C) the Executive’s Retirement (as defined in subparagraph 2(c) below); (D) the Executive’s
termination by the Company for Cause (as defined in subparagraph 2(d) below); or (E) the Executive’s
decision to terminate employment other than for Good Reason (as defined in subparagraph 2(e)
below).
(b) 	If, as a result of the Executive’s incapacity due to physical or mental
illness, the Executive shall have been unable, with or without a reasonable accommodation, to perform
the Executive’s duties with the Company on a full time basis for six months and if, within 30 days after
a Notice of Termination (as defined in subparagraph 2(f)) is thereafter given by the Company, the
Executive shall not have returned to the full time performance of the Executive’s duties, the Company
may terminate the Executive’s employment for “Disability”.
(c) 	The term “Retirement” as used in this Agreement shall mean
Executive’s termination of employment (for any reason other than termination by the Company for
Cause: (i) after attainment of age sixty-five (65) or (ii) after attainment of age fifty-five (55) provided
that Executive has continuously been an employee or consultant to the Company for not less than ten
(10) years.
(d) 	The Company may terminate the Executive’s employment for Cause
before or after a Change in Control. For purposes of this Agreement only, “Cause” shall mean: (i) the
Executive’s commission of acts subject to prosecution as a felony involving moral turpitude; (ii) the
Executive’s material breach of fiduciary duty as an executive officer of the Company which has
resulted, or is likely to result, in material economic damage to the Company; or (iii) the Executive’s
willful gross misconduct or willful gross neglect of duties (other than any such neglect resulting from
the Executive’s incapacity due to physical or mental illness or any such neglect after the issuance of a
Notice of Termination by the Executive for Good Reason, as such terms are defined in subparagraphs
(e) and (f) below and as they may apply under this Paragraph 2); provided that no act or failure to act
by the Executive will constitute “Cause” under clause (ii) if the Executive believed in good faith that
such act or failure to act was in the best interest of the Company.
Any termination of the Executive’s employment by the Company for Cause shall be authorized
by a vote of at least a majority of the independent members of the Board (as they may be determined
by the Board from time to time) within 12 months of a majority of such independent members of the
Board having actual knowledge of the event or circumstances providing a basis for such
termination. In the case of clauses (i) and (ii) of the second sentence of this subparagraph (d), the
Executive shall be given notice by the Board specifying in detail the particular act or failure to act on
which the Board is relying in proposing to terminate the Executive for Cause and offering the
Executive an opportunity, on a date at least 14 days after receipt of such notice, to have a hearing, with
counsel, before a majority of the independent members of the Board, including each of the members of
the Board who authorized the termination for Cause. The Executive shall not be terminated for Cause
if, within 30 days after the date of the Executive’s hearing before the Board (or if the Executive waives
a hearing, within 30 days after receiving notice of the proposed termination), the Executive has
corrected the particular act or failure to act specified in the notice given under clause (ii) of the second
sentence of this subparagraph (d), and by so correcting such
4

-- 41 of 55 --

act or failure to act the Executive has reduced the economic damage the act or failure to act has
allegedly caused the Company to a level which is no longer material or has eliminated the probability
that such act or failure to act is likely to result in material economic damage to the Company. No
termination for Cause shall take effect until the expiration of the correction period described in the
preceding sentence and the determination by a majority of the independent members of the Board that
the Executive has failed to correct the act or failure to act in accordance with the terms of the preceding
sentence. Other than as specified herein, the decision of a majority of the independent members of the
Board of Directors with respect to any determination of the grounds for termination of the Executive’s
employment for Cause shall be binding absent evidence of bad faith or manifest injustice.
(e) 	The Executive may terminate the Executive’s employment for Good
Reason at any time following a Change in Control. For purposes of this Agreement, “Good Reason”
shall mean, after any Change in Control and without the Executive’s express written consent, any of the
following:
(i) 	a significant diminution in the Executive’s duties and
responsibilities, or the assignment to the Executive by the Company of duties inconsistent with the
Executive’s position, duties, responsibilities or status with the Company immediately prior to a Change
in Control of the Company, or any removal of the Executive from or any failure to re-elect the
Executive to any of such positions, except in connection with the termination of employment for
Disability, Retirement or Cause or as a result of the Executive’s death or by the Executive other than
for Good Reason;
(ii) 	a reduction by the Company in the Executive’s annual
rate of base salary as in effect immediately prior to a Change in Control or the Company’s failure to
increase (within 12 months of the Executive’s last adjustment in annual rate of base salary) the
Executive’s annual rate of base salary after a Change in Control of the Company in an amount which at
least equals, on a percentage basis, the average percentage increase in the annual rate of base salary
most recently or then currently being effected for all other executive officers of the Company;
(iii) 	(A) any failure by the Company to continue in effect any
benefit plan or arrangement (including, without limitation, medical, dental, and other established
benefit plans (“Welfare Benefit Plans”), group life insurance and retirement plans) in which the
Executive is participating at the time of a Change in Control of the Company (all hereinafter referred to
as “Benefit Plans”) unless the Executive receives benefits through another plan or arrangement
providing the Executive with benefits, when considered in the aggregate, that are no less favorable than
the benefits under all Benefit Plans available to the Executive at the time of a Change in Control, or (B)
the taking of any action by the Company which would adversely affect the Executive’s participation in
or materially reduce the Executive’s benefits under the Benefit Plans or otherwise deprive the
Executive of any material fringe benefit or perquisite of office enjoyed by the Executive at the time of
a Change in Control of the Company considered in the aggregate with all benefits so provided to the
Executive;
(iv) 	(A) any failure by the Company to continue in effect any
incentive plan or arrangement (including, without limitation, the Company’s incentive bonus and
contingent
5

-- 42 of 55 --

bonus arrangements and credits and the right to receive performance awards and similar long and
short-term incentive compensation benefits) in which the Executive is participating at the time of a
Change in Control of the Company (hereinafter referred to as “Incentive Plans”), (B) the taking of any
action by the Company which would adversely affect the Executive’s participation in any such
Incentive Plan or reduce the Executive’s benefits under any such Incentive Plan, unless in the case of
either subclause (A) or (B) above, there is substituted a comparable plan or program that is
economically equivalent, in terms of the benefit offered to the Executive, to the Incentive Plan being
altered, reduced, affected or ended, or (C) any failure by the Company with respect to any fiscal year to
make an award to the Executive pursuant to each such Incentive Plan or such substituted comparable
plan or program in accordance with its terms or otherwise in a manner consistent with awards or
benefits provided to other executive officers of the Company;
(v) (A) any failure by the Company to continue in effect any plan or
arrangement to receive securities of the Company (including, without limitation, the Company’s stock
option plans and other equity incentive plans as authorized by the Board for the senior executive
officers) in which the Executive is participating at the time of a Change in Control of the Company
(hereinafter referred to as “Securities Plans”), or the taking of any action by the Company which would
adversely affect the Executive’s participation in or materially reduce the Executive’s benefits under any
such Securities Plan or (B) any failure by the Company in any fiscal year to grant stock options, stock
appreciation rights or securities awards to the Executive pursuant to such Securities Plans or otherwise
in a manner consistent with awards or grants provided to other executive officers of the Company; and
provided further that the material terms and conditions of such stock options, stock appreciation rights,
and securities awards granted to the Executive after the Change in Control (including, but not limited
to, the exercise price, vesting schedule, period and methods of exercise, expiration date, forfeiture
provisions and other restrictions) are substantially similar to the material terms and conditions of the
stock options, stock appreciation rights, and securities awards granted to the Executive under the
Securities Plans immediately prior to the Change in Control of the Company;
(vi) 	a relocation of the Company’s principal executive
offices to a location more than 100 miles outside of San Diego, California, or the Executive’s
relocation more than 100 miles from the location at which the Executive performed the Executive’s
duties prior to a Change in Control of the Company, except for required travel by the Executive on the
Company’s business to an extent substantially consistent with the Executive’s business travel
obligations at the time of a Change in Control of the Company;
(vii) 	any failure by the Company to provide the Executive
with the number of annual paid vacation days to which the Executive is entitled for the year in which a
Change in Control of the Company occurs;
(viii) 	any material breach by the Company of any provision of
this Agreement;
(ix) 	any failure by the Company to obtain the assumption of
this Agreement by any successor or assign of the Company;
6

-- 43 of 55 --

(x) 	the Company or its successor no longer is required to
have its common stock registered pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of
1934, as amended; or
(xi) 	any purported termination of the Executive’s
employment by the Company pursuant to subparagraphs 2(b), 2(c) or 2(d) which is not effected
pursuant to a Notice of Termination satisfying the requirements of subparagraph 2(f) below (and, if
applicable, subparagraph 2(d) above), and for purposes of this Agreement, no such purported
termination shall be effective.
For purposes of this subparagraph (e), an isolated, immaterial, and inadvertent action
not taken in bad faith by the Company in violation of clauses (i) – (v), (vii) or (xi) of this subparagraph
that is remedied by the Company promptly after receipt of notice thereof given by the Executive shall
not be considered Good Reason for the Executive’s termination of employment with the Company. In
the event the Executive terminates the Executive’s employment for Good Reason hereunder, then
notwithstanding that the Executive may also be considered retired for purposes of any Company
Benefit Plans (other than the Supplemental Retirement Benefit Plan or other non-qualified plan
providing similar benefits), Incentive Plans or Securities Plans, the Executive shall be deemed to have
terminated employment for Good Reason for purposes of this Agreement.
(f) 	Any termination of the Executive’s employment by the Company
pursuant to subparagraphs 2(b), 2(c) or 2(d), or by the Executive pursuant to subparagraph 2(e) above,
shall be communicated by a Notice of Termination to the other party hereof. For purposes of this
Agreement, a “Notice of Termination” shall mean a written notice which shall indicate those specific
termination provisions in this Agreement relied upon and which sets forth in reasonable detail the facts
and circumstances claimed to provide a basis for termination of the Executive’s employment under the
provision so indicated. For purposes of this Agreement, no such purported termination by the
Company shall be effective without such Notice of Termination.
(g) “Date of Termination” shall mean (i) if the Executive’s employment is terminated
by the Company for Disability, 30 days after Notice of Termination is given to the Executive (provided
that the Executive shall not have returned to the performance of the Executive’s duties on a full time
basis during such 30 day period), (ii) if the Executive’s employment is terminated by the Executive for
Good Reason, the date specified in the Notice of Termination, and (iii) if the Executive’s employment
is terminated by the Company for any other reason, the date on which a Notice of Termination is given;
provided, however, that if within 30 days after any Notice of Termination is given to the Executive by
the Company, the Executive notifies the Company that a dispute exists concerning the termination, the
Date of Termination shall be a date no earlier than the date on which the Notice of Termination is
given, but otherwise, if the termination is to be effective, as of the date so determined, whether by
mutual written agreement of the parties or upon final judgment, order or decree of a court of competent
jurisdiction.
7

-- 44 of 55 --

3. 	Severance Compensation Upon Termination of Employment Following a Change in
Control.
(a) 	If, pursuant to subparagraph 2(a), the Executive is entitled to the
compensation provided for in this Paragraph 3, then, subject to the provisions of Paragraph 7 below
and Paragraph 3(d) below, the Company shall pay to the Executive in a lump sum cash payment, the
following:
(i) 	the Change in Control Severance Amount as defined in
subparagraph 3(b) below within five days following, but not earlier than, the day following the sixth
month anniversary of the Date of Termination; plus
(ii) 	the Executive’s earned but unpaid base annual salary
through the period ending on the Date of Termination within the time required by law for the payment
of wages upon termination of employment; plus
(iii) 	interest, if any, on the amounts payable pursuant to
clauses (i) and (ii) above calculated from the Date of Termination until paid (including interest
calculated for the six month period from the Date of Termination to the date of payment pursuant to
clause (i) or from the Date of Termination to the date of payment pursuant to clause (ii) if not paid
when due) at a rate equal to the prime rate as published in the Wall Street Journal on the Date of
Termination plus three percentage points, compounded annually.
(b) 	“Change in Control Severance Amount” shall mean an amount equal to
the sum of (i) two times the greater of (A) the Executive’s base annual salary in effect as of the Date of
Termination or (B) the average of the Executive’s base annual salary paid for the five full fiscal years
ending prior to the Date of Termination (or, if less, the number of full fiscal years during which the
Executive has been employed by the Company prior to the Date of Termination), plus (ii) two times the
greater of (A) the annual cash bonus awarded by the Board to the Executive with respect to the
Company’s most recent fiscal year ending prior to the Date of Termination or (B) the average of the
annual cash bonus amounts awarded by the Board to the Executive with respect to the Company’s most
recent five fiscal years ending prior to the Date of Termination (or, if less, the number of full fiscal
years during which the Executive has been employed by the Company prior to the Date of
Termination).
(c) 	If, pursuant to subparagraph 2(a), the Executive is entitled to the
compensation provided in this Paragraph 3, then, subject to the provisions of Paragraph 7 below and
Paragraph 3(d) below, the Executive will be entitled to continued participation in all Welfare Benefit
Plans (as defined in subparagraph 2(e)(iii) above) in which the Executive was participating on the Date
of Termination, such continued participation to be at Company cost and otherwise on the same basis as
Company employees generally, until the earlier of (i) the date, or dates, the Executive receives
equivalent coverage and benefits under the plans and programs of a subsequent employer (such
coverages and benefits to be determined on a coverage-by-coverage or benefit-by-benefit basis) or (ii)
two years from the Date of Termination; provided (A) if the Executive is precluded from continuing
participation in any Welfare Benefit Plan as provided in this sentence, the Executive shall be paid a
taxable monthly cash payment equal to the after-tax economic
8

-- 45 of 55 --

equivalent of the benefits provided under the plan or program in which the Executive is unable to
participate for the period specified in this sentence, and (B) the economic equivalent of any benefit
foregone shall be deemed to be the lowest cost that would be incurred by the Executive in obtaining
such benefit (including family or dependent coverage, if applicable) on an individual basis.
(d) 	As a condition to Executive’s receipt of any post-termination benefits
pursuant 	to 	this 	Paragraph 	3, 	Executive 	shall 	execute 	and 	not 	revoke
a general release of all claims in favor of the Company and its affiliates (the “Release”) in form and
substance reasonably satisfactory to the Company (which may include an agreement not to disparage
the Company, non-solicit provisions and other standard terms and conditions). In the event the Release
does not become effective within the fifty-five (55) day period following the Executive’s Date of
Termination, Executive shall not be entitled to the aforesaid payments and benefits. In no event will
severance payments or benefits pursuant to this Paragraph 3 be paid or provided until the Release
becomes effective and irrevocable.
4. 	Company Right to Terminate Employment With or Without Cause; No Obligation of
Executive to Mitigate Damages; No Effect On Other Contractual Rights.
(a) 	Notwithstanding anything to the contrary herein, the Executive shall
serve the Company as an at-will employee and the Company may terminate the Executive’s
employment at any time, with our without Cause subject to the Executive’s right to payment of the
severance compensation provided for herein, if applicable. The Executive hereby acknowledges that
this agreement does not guarantee continued employment with the Company for any period of time and
upon termination of the Executive’s employment, the Executive shall have no claim for compensation
or other benefits pursuant to this Agreement except as specifically set forth herein.
(b) 	The Executive shall not be required to mitigate damages or the amount
of any payment provided for under this Agreement by seeking other employment or otherwise, nor
shall the amount of any payment provided for under this Agreement be reduced by any compensation
earned by the Executive as the result of employment by another employer after the Date of Termination
or otherwise.
(c) 	The provisions of this Agreement, and any payment provided for
hereunder, shall not reduce any amounts otherwise payable, or in any way diminish the Executive’s
existing rights, or rights which would accrue solely as a result of the passage of time, under any Benefit
Plan, Incentive Plan or Securities Plan, or other contract, plan or agreement with or of the Company.
5. 	Options, Securities Awards, And Incentive Awards. 	In the event of a Change in
Control of the Company, then notwithstanding the terms and conditions of any Securities Plan or other
plan, agreement or arrangement, (i) if any Securities Plan will not be continued as to the securities of
the Company or as to substantially equivalent publicly traded securities of the Company or any
successor entity, or (ii) if the Executive’s employment is terminated and the Executive is entitled to the
compensation provided for in Paragraph 3, then the Company agrees to accelerate, vest, and make
immediately exercisable in full all unexercisable installments of all options to acquire securities of the
Company, to vest all unvested awards of securities of the
9

-- 46 of 55 --

Company and to waive any resale or other restrictions or rights of repurchase applicable to securities
underlying such options or applicable to awards of securities of the Company in each case, which are
held by the Executive on the date of such Change in Control or termination of employment, as
applicable, to the extent that the Executive may not otherwise be able to realize the expected benefits
thereof upon continued employment by the Company or a publicly traded successor entity. Such
options or other awards shall be payable in accordance with the terms of the applicable plan, agreement
or arrangement and the award agreement governing such options or other awards.
6. 	Termination. This Agreement shall continue in effect for a period of two (2) years and
shall automatically renew for successive two (2) year periods from the earlier of (a) the next scheduled
termination date, unless the Board provides the Executive with a notice of non-renewal at least 6
months before the next scheduled termination date, or (b) the effective date of a Change in Control.
7. 	Best Pay Provision.
(a) 	In the event that any payment or benefit received or to be received by Executive
pursuant to the terms of any plan, arrangement or agreement (including any payment or benefit
received in connection with a change in ownership or control or the termination of Executive’s
employment) (all such payments and benefits being hereinafter referred to as the “Total Payments”)
would be subject (in whole or part) to the excise tax (the “Excise Tax”) imposed under Section 4999 of
the Code, then the Total Payments shall be reduced to the extent necessary so that no portion of the
Total Payments is subject to the Excise Tax but only if (i) the net amount of such Total Payments, as so
reduced (after subtracting the amount of federal, state and local income taxes on such reduced Total
Payments and after taking into account the phase out of itemized deductions and personal exemptions
attributable to such reduced Total Payments) is greater than or equal to (ii) the net amount of such Total
Payments without such reduction (after subtracting the net amount of federal, state and local income
taxes on such Total Payments and the amount of Excise Tax to which Executive would be subject in
respect of such unreduced Total Payments and after taking into account the phase out of itemized
deductions and personal exemptions attributable to such unreduced Total Payments). Except to the
extent that an alternative reduction order would result in a greater economic benefit to Executive on an
after-tax basis, the Parties intend that the Total Payments shall be reduced in the following order: (w)
reduction of any cash severance payments otherwise payable to Executive that are exempt from Section
409A of the Code, (x) reduction of any other cash payments or benefits otherwise payable to Executive
that are exempt from Section 409A of the Code, but excluding any payment attributable to the
acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A
of the Code, (y) reduction of any other payments or benefits otherwise payable to Executive on a pro-
rata basis or such other manner that complies with Section 409A of the Code, but excluding any
payment attributable to the acceleration of vesting and payment with respect to any equity award that is
exempt from Section 409A of the Code, and (z) reduction of any payments attributable to the
acceleration of vesting or payment with respect to any equity award that is exempt from Section 409A
of the Code; provided, in case of clauses (x), (y) and (z), that reduction of any payments or benefits
attributable to the acceleration of vesting of Company equity awards shall be first applied to equity
awards with later vesting dates; provided, further, that, notwithstanding the foregoing, any such
reduction shall be undertaken in a manner that complies
10

-- 47 of 55 --

with and does not result in the imposition of additional taxes on Executive under Section 409A of the
Code. The foregoing reductions shall be made in a manner that results in the maximum economic
benefit to Executive on an after-tax basis and, to the extent economically equivalent payments or
benefits are subject to reduction, in a pro rata manner.
(b) 	Determinations. All determinations regarding the application of this
Paragraph 7 shall be made by an independent accounting firm or consulting group with nationally
recognized standing and substantial expertise and experience in performing calculations regarding the
applicability of Section 280G of the Code and the Excise Tax retained by the Company prior to the date
of the applicable change in ownership or control (the “280G Firm”). For purposes of determining
whether and the extent to which the Total Payments will be subject to the Excise Tax, (i) no portion of
the Total Payments shall be taken into account which (x) does not constitute a “parachute payment”
within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A)
of the Code) and, in calculating the Excise Tax, or (y) constitutes reasonable compensation for services
actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the “base
amount” (as defined in Section 280G(b)(3) of the Code) allocable to such reasonable compensation, (ii)
no portion of the Total Payments the receipt or enjoyment of which Executive shall have waived at
such time and in such manner as not to constitute a “payment” within the meaning of Section 280G(b)
of the Code shall be taken into account, and (iii) the value of any non-cash benefit or any deferred
payment or benefit included in the Total Payments shall be determined by the 280G Firm in accordance
with the principles of Sections 280G(d)(3) and (4) of the Code. All determinations related to the
calculations to be performed pursuant to this “Section 280G Treatment” section shall be done by the
280G Firm. The 280G Firm will be directed to submit its determination and detailed supporting
calculations to both Executive and the Company within fifteen (15) days after notification from either
the Company or Executive that Executive may receive payments which may be “parachute
payments.” Executive and the Company will each provide the 280G Firm access to and copies of any
books, records, and documents as may be reasonably requested by the 280G Firm, and otherwise
cooperate with the 280G Firm in connection with the preparation and issuance of the determinations
and calculations contemplated by this Agreement. The fees and expenses of the 280G Firm for its
services in connection with the determinations and calculations contemplated by this Agreement will
be borne solely by the Company.
8. 	Successors. The Company will require any successor or assign (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business
and/or assets of the Company, by agreement in form and substance satisfactory to the Executive,
expressly, absolutely and unconditionally to assume and agree to perform this Agreement in the same
manner and to the same extent that the Company would be required to perform it if no such succession
or assignment had taken place. Any failure of the Company to obtain such agreement prior to the
effectiveness of any such succession or assignment shall be a material breach of this Agreement and
shall entitle the Executive to terminate the Executive’s employment for Good Reason and receive the
compensation provided for in Paragraph 3 above (subject to compliance with the notice and cure
provisions set forth in the definition of “Good Reason”). As used in this Agreement, “Company” shall
mean the Company as hereinbefore defined and any successor or assign to its business and/or assets as
aforesaid which executes and delivers the agreement provided for in this Paragraph 8 or which
otherwise becomes bound by all the terms and provisions of this Agreement by operation of law.
11

-- 48 of 55 --

9. 	Survivorship. The respective rights and obligations of the parties hereunder shall
survive any termination of this Agreement to the extent necessary to the intended preservation of such
rights and obligations and to the extent that any performance is required following termination of this
Agreement.
10. 	Notices. Any notice, request, demand or other communication required or permitted
hereunder shall be in writing and shall be deemed to be properly given when personally served, when
deposited in the United States mail, postage prepaid, or when communicated by facsimile or email,
addressed to the Company at its head office location or the Executive at the Executive’s last known
address. Either party may change its address by written notice in accordance with this paragraph.
11. 	Benefit of Agreement. This Agreement shall inure to the benefit of and be
enforceable by the Executive’s personal and legal representatives, executors, administrators,
successors, heirs, distributees, devisees and legatees. If the Executive should die while any amounts
are still payable to the Executive hereunder, all such amounts, unless otherwise provided herein, shall
be paid in accordance with the terms of this Agreement to the Executive’s devisee, legatee or other
designee or, if there be no such designee, to the Executive’s estate.
12. 	Applicable Law; Venue. Except to the extent governed by the laws of the United
States, this Agreement is to be governed by and construed under the laws of the State of
California. Any suit brought hereon shall be brought in the state or federal courts sitting in San Diego
County, California, the parties hereto hereby waiving any claim or defense that such forum is not
convenient or proper. Each party hereby agrees that any such court shall have in personam jurisdiction
over it and consents to service of process in any manner authorized by California law.
13. 	Captions and Paragraph Headings. Captions and paragraph headings used herein are
for convenience only and are not a part of this Agreement and shall not be used in the interpretation of
this Agreement.
14. 	Invalid Provisions. Should any provision of this Agreement for any reason be declared
invalid, void or unenforceable by a court of competent jurisdiction, the validity and binding effect of
any remaining portion shall not be affected, and the remaining portions of this Agreement shall remain
in full force and effect as if this Agreement had been executed with said provision eliminated.
15. 	Entire Agreement. This Agreement contains the entire agreement of the parties. It
supersedes any and all other agreements, either oral or in writing, between the parties hereto with
respect to the matters covered herein, including, without limitation, the Prior Agreement. Each party to
this Agreement acknowledges that no representations, inducements, promises, or agreements, oral or
otherwise, have been made by any party, or anyone acting on behalf of any party, which are not
embodied herein, and that no other agreement, statement, or promise relating to the matters covered
herein and not contained in this Agreement shall be valid or binding. This Agreement may not be
modified or amended by oral agreement, but only by any agreement in writing signed by an authorized
officer of the Company and the Executive.
12

-- 49 of 55 --

16. 	Attorney’s Fees. If any action, including arbitration, is brought to enforce this
Agreement or to determine the relative rights and obligations of either of the parties and a ruling is
obtained in favor of either party, regardless of which party institutes the action, the prevailing party will
be entitled to reasonable attorney’s fees.
17. 	Section 409A.
(a) 	The intent of the Company and Executive is that the payments and benefits
under this Agreement comply with or be exempt from Section 409A of the Code (“Section 409A”) and,
accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance
therewith. If the Company and the Executive agree in good faith that the payments and benefits under
this Agreement would not comply with Section 409A, the parties hereto shall reasonably and in good
faith attempt to modify this Agreement to comply with Section 409A while endeavoring to maintain the
intended economic benefits hereunder.
(b) 	Notwithstanding anything in this Agreement to the contrary, (i) any
compensation or benefits payable under this Agreement that is designated under this Agreement as
payable upon the Executive’s termination of employment shall be payable only upon Executive’s
“separation from service” with the Company within the meaning of Section 409A (a “Separation from
Service”).
(c) 	Notwithstanding anything in this Agreement to the contrary, if the Executive is
deemed by the Company at the time of Executive’s Separation from Service to be a “specified
employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the
benefits to which the Executive is entitled under this Agreement is required in order to avoid a
prohibited distribution under Section 409A, such portion of the Executive’s benefits shall not be
provided to the Executive prior to the earlier of (x) the expiration of the six-month period measured
from the date of the Executive’s Separation from Service with the Company or (y) the date of
Executive’s death. Upon the first business day following the expiration of the applicable Section 409A
period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to
Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under
this Agreement shall be paid as otherwise provided herein.
(d) 	To the extent that any reimbursements under this Agreement are subject to
Section 409A, (A) any such reimbursements payable to the Executive shall be paid to the Executive no
later than December 31 of the year following the year in which the expense was incurred, (B) the
Executive shall submit the Executive’s reimbursement request promptly following the date the expense
is incurred, (C) the amount of expenses reimbursed in one year shall not affect the amount eligible for
reimbursement in any subsequent year, other than medical expenses referred to in Section 105(b) of the
Code, and (D) the Executive’s right to reimbursement under this Agreement will not be subject to
liquidation or exchange for another benefit.
(e) 	The Executive’s right to receive any installment payments under this
Agreement, including without limitation any continuation salary payments that are payable on
Company payroll dates, shall be treated as a right to receive a series of separate payments and,
accordingly, each such installment payment shall at all times be considered a separate and distinct
13

-- 50 of 55 --

payment as permitted under Section 409A. Except as otherwise permitted under Section 409A, no
payment hereunder shall be accelerated or deferred unless such acceleration or deferral would not
result in additional tax or interest pursuant to Section 409A.
14

-- 51 of 55 --

/s/ STEVEN A. BRASS
Steven A. Brass
Chief Executive Officer
Exhibit 31(a)
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Steven A. Brass, certify that:
1. I have reviewed this report on Form 10-Q of WD-40 Company;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of,
and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the Registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred
during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control
over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of
directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process,
summarize, and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the Registrant’s internal control over financial reporting.
Date: January 9, 2023

-- 52 of 55 --

/s/ SARA K. HYZER
Sara K. Hyzer
Vice President, Finance, Treasurer and Chief Financial Officer
Exhibit 31(b)
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Sara K. Hyzer, certify that:
1. I have reviewed this report on Form 10-Q of WD-40 Company;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of,
and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the Registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in
which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and
d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred
during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control
over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of
directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process,
summarize, and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the Registrant’s internal control over financial reporting.
Date: January 9, 2023

-- 53 of 55 --

/s/ STEVEN A. BRASS
Steven A. Brass
Chief Executive Officer
Exhibit 32(a)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Steven A. Brass, Chief Executive Officer of WD-40 Company (the “Company”), have reviewed the Quarterly Report on Form
10-Q of the Company for the quarter ended November 30, 2022 (the “Report”). For purposes of Section 1350 of Title 18, United States
Code, I certify that to the best of my knowledge:
(1) 	the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended; and
(2) 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.
Date: January 9, 2023

-- 54 of 55 --

/s/ SARA K. HYZER
Sara K. Hyzer
Vice President, Finance, Treasurer and Chief Financial Officer
Exhibit 32(b)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Sara K. Hyzer, Chief Financial Officer of WD-40 Company (the “Company”), have reviewed the Quarterly Report on Form 10-Q
of the Company for the quarter ended November 30, 2022 (the “Report”). For purposes of Section 1350 of Title 18, United States Code, I
certify that to the best of my knowledge:
(1) 	the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended; and
(2) 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.
Date: January 9, 2023

-- 55 of 55 --